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Absorption and distribution of any new drug candidate remain imperative components in the 
drug development process. For more than four decades, researchers have actively embarked on 
finding alternative ways to replace the use of human skin samples for in-vitro measurement of 
model drug absorption profiles. More recently, the use of polymeric materials has gained wide 
consideration as a viable alternative, largely due to physicochemical semblance that can be 
drawn from some of these polymeric membranes in comparison with the skin. However, an 
empirical resolve, strong enough to replicate surface activity of the skin, in terms of permeation 
data is yet to be achieved, which then necessitates the need to look for further approaches.   
In this study, one of the polymer membranes widely considered as a potential skin mimic 
namely, poly(dimethylsiloxane) PDMS was studied and consequently, was chemically 
modified in an attempt to address some of the many constraints associated with the use of 
human skin samples. 
In the first phase of the study, PDMS membrane was plasma treated using an atmospheric 
pressure non-thermal air plasma technique; structurally, this process replaces surface methyl 
groups present on the membrane surface with hydroxyl groups, thereby making the surface of 
the membrane susceptible for chemical treatments and grafting. This process was followed by 
silanisation processes using various active saline reagents such as dimethylphenylsilanol, 
tertbutyldimethylphenylsilanol, pentan-1,5-diol to mention but a few. A modified form of the 
membrane was characterised with a range of relevant analytical techniques such as scanning 
electron microscopy (SEM), water contact angle (WCA) analysis, Brunauer-Emmett-Teller 
(BET) technique and attenuated total reflectance-Fourier transform infrared spectroscopy 
(ATR-FTIR). Comparative permeation analysis was carried out between standard PDMS 
membrane and modified forms of the membrane, and drug permeation profiles were quantified 
using ultraviolet-visible spectroscopy (UV-vis) and high-performance liquid chromatography 
(HPLC) techniques.  
As part of this research work, the concept of ‘smart polymers’ was also studied. 
Poly(dimethylsiloxane)-poly(ethylene oxide) block co-polymer (PEG-BCP) was identified and 
grafted onto plasma-treated PDMS membrane. The resultant membrane formed was able to 
smartly re-orient itself and selectively respond to changes based on sample drug hydrophilicity.  
Overall, over-estimation of percutaneous absorption (which is a lingering constraint 
experienced with the use of polymeric membranes in permeation analysis) was remarkably 
reduced and reported difficulties experienced with analysing hydrophilic drugs, such as 
caffeine, were also addressed. Structural integrity, activity and selectivity of the membrane was 
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There is considerable interest in utilising the skin as a route for drug delivery, thus requiring 
assessment of percutaneous absorption. The early stages of the transdermal drug development 
process rely heavily on skin permeation data, largely obtained from permeation analysis using 
human skin. However, in the initial development of a new drug candidate, such studies using 
human skin are practically not feasible, due to the shortage in availability of skin and how 
costly it can be. Also, given the number of experiments required before any medicine is fine 
tuned for clinical studies, further explains how difficult it is to rely on human skin for such 
purposes. However, the concept of using a transdermal drug delivery system (TDDS) has 
continued to be widely explored and considered, and this is due to the numerous advantages 
this route of drug administration offers. It is almost impossible to not consider this route of 
drug delivery in this era of human development, thus, in an attempt to address human skin 
availability which tends to impede development of this system and pose one of the major 
challenges in biopharmaceutical transdermal research, a promising approach involves the use 
of sustainable and synthetic polymeric membranes. The development of these membranes 
would not only address availability concerns often associated with human skin samples, but 
would also provide a shorter and more economical drug development process (Godin & 
Touitou, 2007). Hence, the creation of an alternative membrane that can correlate human data 
for prediction of percutaneous absorption in TDDS is critically needed.  
Prior to consideration of synthetic membranes in the percutaneous absorption research 
processes, their broad application in biochemical related fields such as gas separation 
(Restrepo‐Flórez & Maldovan, 2019), (Vopička, Randová, & Friess, 2014) and ultrafiltration 
have resulted in an increase in their production and characterisation, hence, concerns related to 





Sanderson, & G. J. P. Eccleston, 2010b). Specifically, in the area of TDDS, these polymers and 
some of their additives have not only eased availability and cost-related concerns but have also 
provided an extensive database with numerous designs and flexibility for diverse applications. 
An impressive technical know-how that encompasses physicochemical and mechanical 
properties of various polymers commercially available has also been achieved and 
documented, making it even easier to apply in TDDS. More recently, polymers are considered 
the backbone of TDDS (Kandavilli, Nair, & Panchagnula, 2002). 
Despite the extensive commercialisation of the polymer industry, there are limitations in terms 
of commercially available membranes that are suited for TDDS, especially considering the 
numerous and distinct properties required of such membranes. This is because commercial 
demands to develop a certain polymer for a specific purpose may still not address all the 
specific qualities needed for an effective TDDS membrane. The ability to create modifications 
is a promising advantage polymeric membrane offers, which largely addresses issues relating 
to specifics needed for certain purposes. It is well established that most of the conventional 
polymers produced in bulk do not necessarily meet the demand required for both their bulk and 
surface properties, especially when considered as biomaterials (Ikada, 1994). Therefore, 
materials proven to have excellent bio-functionality could be identified, modified and tailored 
appropriately to give a better clinically applicable material. These materials (although modified 
mostly only at the surface) could give new functionalities such as increased hydrophilicity, 
biocompatibility, adhesion, conductivity, anti-fogging and anti-fouling, amongst other 
properties (Uyama, Kato, & Ikada, 1998). Based on this knowledge, researchers are embarking 
on polymer modification processes, thereby bridging the gap between the numerous advantages 
of polymers and some of the distinct features they may lack for more specific purposes. It is 
also safe to say certain developments associated with such research have led to the production 





1.1.2. Model Polymeric Membranes for TDDSs 
Generally, polymeric membranes considered effective for drug permeation studies can be 
grouped as porous and non-porous membranes, and the mechanism through which drug 
compounds pass through them differs depending on which membrane type is used. In the case 
of a non-porous membrane, the drug molecule passes through the membrane via diffusion 
across a concentration gradient with the major influential factor being the drug molecules 
ability to adsorb on the membrane surface. Considering these factors, scientists have been able 
to cascade the three stages of permeation on these membranes,  (S Ebnesajjad & Khaladkar, 
2005; Sina Ebnesajjad & Morgan, 2019) : 
1. Liquid take-up on the membrane surface, mainly determined by solubility 
parameters and the surface chemistry of the membrane 
2. Migration of the liquid via the membrane matrix (determined by diffusivity), and 
3. Desorption from the membrane once diffused. 
Porous membranes on the other hand, are more utilised in separation processes based on drug 
molecule size, provided any interaction between the membrane and molecule is avoided, a sort 
of sieving mechanism is employed in this approach. Such membranes are often used in 
ultrafiltration studies.  
When trying to mimic percutaneous absorption of the skin, non-porous membranes have been 
reported as better alternatives over the porous membranes. This is largely attributed to 
comparisons with reported permeation profiles using human skin. Hence, non-porous 
membranes are considered more closely related to the skin due to their relatively low 
permeation (Misra, 2014). 
To better utilise synthetic polymeric membranes for investigating transdermal permeation, 





approaches have been considered. Methods involving co-polymerisation are amongst the most 
widely reported approaches. This approach is interesting as the principle behind it is to mimic 
the morphological structure of the skin. An example is polydimethylsiloxane-polycarbonate 
copolymers. Reported selectivity of polydimethylsiloxane was harnessed in this system, 
alongside the ultra-sieving nature of the polycarbonate co-polymer. Fourteen model drugs were 
used in this particular report, spanning a wide range of therapeutic classes. Permeability 
coefficients of these drugs across an actual skin membrane were determined and analysed, 
physicochemical parameters such as permeant molecular weight, octanol-water partition 
coefficient, solubility in aqueous solution and melting point were also considered. Results 
obtained using the actual human skin sample were then compared with results obtained from 
the synthetic membranes. There was a significant relationship between the two membranes (R2 
= 0.886) but this approach experienced phase segregation between the two co-polymers, which 
is a major problem with copolymers (Feldstein, Raigorodskii, Iordanskii, & Hadgraft, 1998), 
and as such was not considered an effective alternative at the time. 
Another interesting approach previously attempted was by creating an artificial lipid membrane 
using isopropyl myristate (IPM), which was principally chosen to represent barrier function of 
the stratum corneum (top layer of the skin) (Hadgraft & Ridout, 1987). This approach was also 
inspired by skin morphology, which guided their choice of selection. Although a positive 
correlation was demonstrated in transport resistance between IPM and excised human skin, this 
approach still suffered from low resistance when compared with actual skin, it was therefore 
suggested in the paper that further modifications should be made to improve predictability and 
stability of the system. 
Synthetic membranes such as cellulose nitrate (Borgia, Schlupp, Mehnert, & Schäfer-Korting, 





amongst others, have also been used in skin mimicry studies with poor correlation compared 
with excised human skin.  
However, Borgia et al (Borgia et al., 2008) and Shiow-Fern et al (S.-F. Ng, Rouse, et al., 2010b) 
have separately reported in their findings that silicon membrane has proven superior compared 
with other synthetic polymers such as polyether sulfone, polycarbonate or cellulose nitrate. 
Silicon membranes distinctly exhibit mechanistic diffusion of materials similar to the stratum 
corneum, as a consequence of their non-porous nature and compound selectivity. More 
specifically, silicon membranes have the ability to maintain penetrant permeation profiles via 
a concentration gradient. Moreover, differences in the permeation amongst different permeants 
remains a subjective measure which is a function of concentration and diffusivity of the 




















1.2. Literature Review  
This section summarises the strengths, weaknesses, opportunities and challenges of this study. 
Challenges that may have prevented development of a cost-effective alternative prior to this 
study are also highlighted. 
1.2.1. Prospects in Transdermal Drug Delivery Systems 
 Routes for drug delivery are broadly divided into three categories, namely, the oral route, 
intradermal route and the transdermal route. The oral drug delivery route has been reported as 
the most popular route of drug delivery; an online journal released a report in June 2019 
estimating the sale of pain relief drugs at a value of £628.6 million, with the Nurofen brand 
having the highest sale value of £93 million (Statista, 2019), and this is excluding cold, cough, 
sore throat, vitamins and minerals medication. Notwithstanding this popularity, approximately 
74 % of drugs taken orally have been reported not to be as effective as desired (Marwah, Garg, 
Goyal, & Rath, 2016). The intradermal drug delivery route on the other hand, has been reported 
to suffer from low patient compliance, due to its invasive method of delivery, especially by 
patients that require routine medications. The third option is the transdermal drug delivery 
route, which utilises the skin (with a large surface area) for drug delivery. Studies has  shown 
increased patient compliance when using this route for drug delivery purposes (Thomas & 
Finnin, 2004). Other advantages in using the skin for drug delivery purposes includes 
minimised systematic delivery to other sites, as well as a reduced likelihood of uncertain 
absorption from degradation by stomach acid and enzymes. It also eliminates the need to use 
needles (or their  re-use), which is still a problem particularly in developing countries 
(Bartosova & Bajgar, 2012), (Waghule et al., 2019). Other advantages include reduced 
hospitalisation and the release of drug via this route can be sustained and controlled (Pegoraro, 





delivery a basis of several billion–dollar industries, such as cosmetics, pharmaceutical and 
personal care industries (Menon, 2002). This has also made TDDSs a rapid area of research 
and development. 
In addition, new medicines are constantly designed for topical administration. A substantial 
number of existing drugs are also re-formulated from their original oral forms to creams, gels 
or ointments to utilise this promising transdermal route. Typical examples of these re-
formulated drugs include ibuprofen gel and diclofenac gel. Another major reason why some of 
these drugs are re-formulated is as a result of studies carried out to compare efficacies and 
adverse effects between oral and topical forms of a drug. Findings  have suggested that in terms 
of efficacy, there were no significant differences drawn either from the primary efficacy 
endpoint, the median rated time for the injury to be considered completely better by the patients 
or other efficacy measures, including clinical relief from pain or swelling (Whitefield, O'Kane, 
Anderson, & therapeutics, 2002).  
Moreover, despite a proven effectiveness in the oral forms of non-steroidal anti-inflammatory 
drugs (NSAIDs), (mostly prescribed for musculoskeletal and soft tissue injuries) over the years, 
a major concern is their propensity to induce duodenal or gastric ulceration (Sanna, Peana, & 
Moretti, 2009). Studies have shown a significant number of patients (68 %) taking the oral 
form of an NSAID experience peptic ulceration, perforation, mucosal erosion or bleeding 
(Andrianakos et al., 1992). On the other hand, there have been rare reports suggesting adverse 
effects associated with topical forms of these drugs (Fernando, Thomas, Temple, & Lee, 1994), 
(Moore, Tramer, Carroll, Wiffen, & McQuay, 1998) and (Patil, Datir, Saudagar, & 
Therapeutics, 2019). These findings further encouraged researchers to develop more 
compounds with a wide range of therapeutic classes in a topical form, thereby providing a 





recent examples of drugs converted to transdermal formulations are compounds for the 
treatment of diseases such as Parkinson’s and Alzheimer’s which are currently in their final 
stages of development (Benson, Grice, Mohammed, Namjoshi, & Roberts, 2019). Also, within 
America alone, more than 35 transdermal products have already been approved to treat 
conditions ranging from hypertension, female menopause, severe pain from local muscle 
injuries, contraception, eczema, psoriasis and nicotine dependence, amongst others (Hillery, 
Lloyd, & Swarbrick, 2002). Misra et al also highlighted the increasing level of support from 
the pharmaceutical industry towards supporting this alternate route of drug delivery (Misra, 
2014) . 
Another key factor when considering TDDS is the concept of controlled drug release which it 
exemplifies, by not only minimising drug side effects but also optimised therapeutic efficacies 
by maximising bioavailability. Common examples are insulin patches for diabetic patients, 
nicotine patches for addiction withdrawal purposes, along with many other forms of these 
marketed compounds. The non-invasive nature, convenience and prolonged administration of 
therapeutic agents from these wearable TDDS remains a cornerstone in this field. 
However, just like other forms of drug delivery processes, topical administration of drugs also 
has several issues of concern, necessitating evaluation in efficiency of these novel formulations 
before administration to the skin. These concerns include the fact that there is a continuous 
application of therapeutic compound on the skin, raising issues such as the potential to cause 
skin cancer (Klimová, Hojerová, & Beránková, 2015). Or, in the case of formulations such as 
sunscreen, can cause blockages of skin surface pores, which may decrease efficiency (Klimová 
et al., 2015). It also remains a challenge to researchers when trying to overcome the primary 





As a consequence of this, there has been a lot of research within this area, not only to propose 
alternative formulations but to also enhance, optimise and mitigate certain issues related to 
such systems (Malvey, Rao, & Arumugam, 2019), (Anissimov & Roberts, 2011). 
1.2.2. Topical and Transdermal Drug Delivery  
It is important to highlight that utilising the skin for drug delivery purposes has been used for 
many years. Galen’s classical formulation of cold cream, which is still in use today with some 
modifications, is evidence of this aged practice (Hadgraft & Lane, 2005). Although, TDDS 
pre-date recorded literature, recent advancements in biophysical techniques have paved the 
way for more appreciation in terms of the therapeutic usefulness of this route. More recently, 
researchers have been able to navigate and shape understanding in this field, owing to the 
commercialisation of several transdermal delivery systems. However, a mechanistic 
understanding of this route remains a concern. Scientists suggest a more detailed understanding 
still needs to be achieved in terms of the skin structure, which will then help when trying to 
develop an alternative to skin that can mimic how it functions. 
1.2.3. Research Statement 
Primarily, this research focuses on developing and modifying a synthetic polymeric membrane 
that can be used for transdermal drug development and research purposes in place of skin (both 
human and animal) for the prediction of skin permeation. It is, therefore, necessary to consider 
the structure and mechanistic properties of skin, particularly human skin, and understand how 
materials are transported through skin, so as to have an informed position and background as 
to what type of alternative is actually needed to address the many challenges associated with 





 As part of the initial research, concerted efforts were made to identify a promising skin mimic 
membrane, which was then modified in an attempt to create a better fit for permeation analysis, 
thus achieving the production of a suitable alternative to skin. 
1.2.4. Structure and Mechanism of Permeation Through the Skin 
The skin is the largest organ of the human body (Ghafourian, Samaras, Brooks, & Riviere, 
2010), it consists of complex tissues, each performing a distinct function based on its cell type. 
It defines the boundary between the human body and its surrounding, thus, allowing selective 
movement of material in and out of the body, and at what rate (K. W. Ng & Lau, 2015). This 
is the primary function of skin (Menon, 2002) along with maintenance of constant internal 
conditions. The skin can be broadly divided into three different layers; the epidermis, dermis 
and the hypodermis or subcutaneous tissue (Shahzad, Louw, Gerber, & Du Plessis, 2015). The 
epidermis represents the outermost layer of the skin which can further be subdivided 
histologically into five distinct sub-layers, namely: stratum corneum (horny layer), stratum 
granulosum (granular layer), stratum spinosum (prickle cell layer), and stratum basale (also 
called the stratum germinativum). The stratum basale and stratum spinosum are sometimes 
collectively referred to as the Malpighian layer (K. W. Ng & Lau, 2015).   
The stratified epidermis is mainly made up of keratinocyte cells and these cells synthesise the 
protein called keratin. This protein is in a constant state of growth and transition from which 
the division of these distinct sub-layers emerge. The growth and transition are such that it starts 
from the deeper sublayer to the superficial stratum corneum and each sub-layer typically 
represents a certain stage of keratin maturation (Malvey et al., 2019). Stratum basale which 
forms the innermost layer, is attached to the basement by a protein bridge called desmosomes, 
this protein also connects sub-layers of keratinocytes which are in a constant state of division. 
In the stratum basale, the keratinocytes are able to grow and differentiate continuously, pushing 





which produce melanin, the pigment responsible for pigmentation and provides a shielding 
effect from ultraviolet radiation, hence chronic exposure to light increases the melanocyte ratio 
when compared to keratinocytes (Malvey et al., 2019).  
As the basal cells continue to grow and mature, they form  the stratum spinosum consisting of 
cells with many sides, the keratinocytes at this division, when viewed at a microscopic level 
form spin-like projections owing to the name ‘spinosum’(L. A. Cole & Kramer, 2015). They 
play an important aspect in immune reactions of the skin. As opposed to the prickled 
keratinocytes in the stratum spinosum, the stratum granulosum which is the next sub-layer of 
the epidermis consists of flattened keratinocytes with granules from which a hydrophobic lipid 
is released. This lipid helps protect the body from loss of excessive fluid, while also 
contributing to guarding the entry of foreign substances into the body. At this stage, the cells 
also lose their nuclei and cytoplasm forming granules that contributes to their water retention 
capacity. These lower three sub-layers within the epidermis collectively are referred to as the 
viable epidermis, because 95 % of the keratinocytes are viable (Tobin, 2006). 
At this stage of the keratinocyte development, the cells become enucleated, flattened and lack 
cellular organelles, forming the superficial layer known as the stratum corneum which serves 
as the principal sub-layer that mainly provides the barrier property of skin (Choe, Lademann, 
& Darvin, 2016). This barrier property provided by the stratum corneum makes it the most 
interesting layer to study when considering the overall barrier property of the skin.  
The stratum corneum and stratum lucidium (the latter only present in thick skin of the body, 
such as soles of the feet and palms of the hand) form the outermost layers of skin. Skin owes 
its selective absorption and barrier functions mainly to the stratum corneum (the primary 
barrier). This function is possible as a consequence of the unique composition of the stratum 
corneum and can be envisaged from a theoretical point of view as a ‘bricks and mortar’ 





which are both key determinants of skin permeability and, in turn, relates to drug permeation 
through the skin. It is this structure-activity relationship that permits prediction of drug 
permeation (K. W. Ng & Lau, 2015). 
It is important to note that detailed structure of the skin is still circumstantial and remains an 
interesting area of research for scientists (Lundborg et al., 2018), therefore, to fully understand 
TDDS, it is paramount to focus more on the main theories that try to explain the skin structure 
more specifically, as it relates to its barrier functions.  
Advances in TDDS are largely attributed to understanding the mechanism behind skin 
permeation. Studies in this field suggests a chemical defence property is exhibited by the skin. 
Efforts, therefore, were channelled towards understanding, identifying and studying the 
stratum corneum as this is known to be responsible for this barrier or defence property. 
Routes of drug delivery via the skin surface have been debated over the years, and it has not 
yet been unequivocally resolved (Hadgraft & Lane, 2005). However, this discussion will focus 
on the plethora of evidence that supports some of the more popular claims. It is widely accepted 
that permeation of drugs occurs via the intact area of the stratum corneum and that the skin 
appendages or trans-appendageal pathways, only provide negligible amounts of permeable 
substance compared to the overall permeation profile of any xenobiotic permeating the skin at 
a steady state. It is argued under this context that the appendageal pathways grossly occupy an 
average of 0.1 % of the total skin surface (Lane, 2013), and a fraction of these pathways are 
sometimes blocked by dried sebum or have to compete with outflow of sebum from hair 
follicles (Moss, Gullick, & Wilkinson, 2016). Even though xenobiotics (especially water 
soluble or ionic compounds) might permeate this route faster compared to the intact area of the 
stratum corneum, it is believed that the relative contribution is still negligible. Furthermore, 





spectroscopic techniques and radiolabelled compounds to determine the actual route of drug 
transport via the skin. Attenuated total reflectance (ATR) infrared spectroscopy for instance, 
was used to quantify drug components on the skin surface following topical application over a 
specified period of time. Skin conductivity and impedance measurement on skin was also used 
to research and described the structure of the skin, and consequently transport of material via 
the skin. Transmission electron spectroscopy (TEM) was also used to describe the ultra-layered 
structure of skin. All these findings pointed at the intact part of the stratum corneum as the 
main route for drug delivery. The mechanism and potential of using an intact part of the stratum 
corneum for drug delivery was further exemplified by transdermal drug delivery of 
nitroglycerin to the myocardium for the treatment of Angina pectoris in 1989. It was reported 
in the paper, that for any drug topically administered, it has to be distributed first into the 
papillary layer following skin permeation, through to the capillary network, before distribution 
to target tissues with the help of blood capillaries embedded within inner layers of the skin, as 





Figure 1. 1 Systemic illustration of transport route across layers of the skin 
This finding and many other findings alike, contributed to understanding how transport of 
materials via the skin occurs, thus paving the way for rapid development of TDDS in the 
1980’s. However, within the intact part of the stratum corneum, there is a plethora of evidence 
that suggests a well-defined hetero-type composition exists between corneocytes and an 
intercellular lipid region. This region was described as a structurally complex and presumably 
lipid rich region which provides a continuous pathway through the skin. If this is the case, then 
scientists suggest that stacking of the corneocytes becomes an area of interest when trying to 
predict the mechanism of permeation, since their composite materials are distinct and may react 
differently to xenobiotics. A structure was then proposed in 1975 by Michael et al which tries 
to propose a layered structure of the skin (Michaels, Chandrasekaran, & Shaw, 1975) with a 
semblance of  bricks and mortar wall. This arrangement that exemplifies a heterogeneous skin 






Figure 1. 2 Schematic representation of the ‘Bricks and mortar’ model 
The ‘bricks and mortar’ model of the stratum corneum allows a conceptualisation of how the 
skin works. The corneocytes (bricks), which are largely agreed as terminally differentiated 
keratinocytes are comprised mainly of keratin microfibers, and are protected externally by a 
cornified cell envelop, held together by desmosomes protein (Hoath, 2014a) (Feingold & Elias, 
2014). The intercellular lamellar (mortar) lipid membrane comprises of three different lipid 
components, found in approximately a 3:1:1 relative ratio, based on the stratum corneum - lipid 
composition (%  by weight) which comprises of ceramide (50 %), free fatty acid (10-15 %) 
and cholesterol (25 %) (Feingold & Elias, 2014). It is important to note that these lipids, are 
produced from lamellar bodies within the stratum granulosum, some of which (upon entry into 
the stratum corneum, after extrusion) are converted enzymatically to ceramides (Del Rosso & 
Levin, 2011). 
Ceramide plays a vital role in the water retention capacity of the stratum corneum, this is 
evidenced by the fact that any change in the percentage composition of the stratum corneum 
can result in skin diseases such as psoriasis and eczema. (Imokawa, Akasaki, Hattori, & 
Yoshizuka, 1986). Some of these diseases play an essential role in understanding barrier 





understanding of membrane permeability. Unsaturated free fatty acid has been suggested also 
to contribute in disrupting the barrier structure of the stratum corneum (Meckfessel & Brandt, 
2014), and is known to exist as sebaceous contamination (Harding, 2004). Linoleic and oleic 
acid are believed to be the only two members of the fatty acid group that are not bound and are 
unsaturated. Linoleic acid particularly, plays a vital role in controlling the loss of trans 
epidermal water (Prottey, 1976). Cholesterol provides the needed fluidicity to the stratum 
corneum at room temperature (Zbytovská et al., 2008), which prevents the skin from being 
brittle. Additionally, cholesterol sulphate (which constitutes about 2-5 % of the stratum 
corneum lipids), helps in the formation of the lipid lamellae and serves as a laminating agent 
which in turn gives the stacked parallel nature of the stratum corneum, thus, stabilising it (Sato, 
Nakanishi, Denda, Nomura, & Koyama, 1997). It is on this basis, that the majority of 
mechanisms for drug permeation via the skin are built. Recently, Hoath et al (Hoath, 2014b) 
also reported the intercellular lipid region as the only continuous route through the stratum 
corneum. In other words, the intercellular route is predominantly packed with lipophilic 
compounds, and substances can only pass through them via physicochemical interaction in a 
description shown in Figure 1.3. 
Dermis is the second layer of human skin, found underneath the epidermis. It comprises of two 
distinct layers namely; papillary layer (superficial layer) (Figure 1.1) and the reticular or 
capillary layer (Lai-Cheong & McGrath, 2017). The papillary layer is thinner and has contact 
with the epidermis through its loose connective tissue (Yousef, Alhajj, & Sharma, 2019). It has 
an extensive network of blood vessels which helps in providing needed nutrients that are 
utilised in producing keratinocyte cells in the epidermis. It also helps in removing excess waste 
(cellular waste) from the skin which otherwise will be harmful if left to accumulate. The result 
of these activities generates heat which helps provide maintenance of internal temperature. The 





responsible for providing strength and elasticity respectively. Hence, perturbation in molecular 
organisation of this protein network results in a compromise of the skins mechanical properties 
leading to a reduced resilience and elasticity (M. A. Cole, Quan, Voorhees, & Fisher, 2018). 
These nerves are also responsible for transport of xenobiotics into the body system via blood 
streams. 
The hypodermis (often referred to as subcutaneous tissue) is adipose tissue. It is the deepest 
layer of the skin after the dermis. It contains fat deposits, and due to the well-integrated nature 
with the dermis, it contains hair follicles, skin appendages, blood vessels and sensory neurons 
(Yousef et al., 2019).  
 
 
    





1.2.5. Permeation theory and measurements  
Quantitative measurements of materials across the skin can never be over-emphasised and are 
of paramount importance to scientists concerned with TDDS. Principles that govern this 
transport of materials via the skin such as permeation rate after attaining a steady-state, 
breakthrough time and cumulative drug release over a therapeutic window are equally 
important for mechanistic understanding of the process. These parameters are achieved and 
monitored by permeation analysis processes, which ultimately determines the suitability of a 
drug for TDD. The principle behind permeation of drugs when applied to the skin, can best be 
described by Fick’s first law of diffusion. The law states that ‘flux in a certain direction is 
directly proportional to the concentration gradient’ (Equation 1.1), this is however, under the 
assumption of a steady state (Comyn, 1985).  
 
              J = D 
𝑑𝐶
𝑑𝑥
            Equation 1.1 
Where J is diffusion flux (or sometimes referred to as the permeant flux), reported in units of 
mol m-2 s-1, or in the case of lower concentration, it can be units of µg cm-2 s-1. D is the diffusion 
coefficient in units of m2 s-1 or cm2 s-1, C is the concentration of the permeant in mol cm-3 or in 
µg cm-3 as the case might be, and x is the position, or spatial dimension of the membrane surface 
thus represented in units of m or cm.  
The in vitro analytical permeation process is such that it comprises of a donor phase and 
receptor phase, where a pre-heated membrane is carefully mounted between these two phases. 
Often in analysis a saturated solution is mounted on the membrane surface within the donor 





a stable temperature and prevent the loss of solvent through evaporation (S.-F. Ng, J. Rouse, 
D. Sanderson, & G. Eccleston, 2010a).  
During the permeation process it is important to maintain sink conditions, whereby the receptor 
compartment would have zero-drug concentration. This condition is challenging to achieve 
when using static cells (S.-F. Ng, Rouse, Sanderson, Meidan, & Eccleston, 2010), and this led 
to the development of a system known as the flow-through system, which takes into 
consideration variables such as temperature, stirring, and flow rate. Temperature is an 
important property in permeation studies, it immensely affects passive diffusion of drugs, and 
the ideal temperature within the membrane matrix is expected to be maintained at 32 °C ± 1 
°C. It has been reported that an increase in temperature affects permeation profiles. For 
example, approximately 8 °C increase in temperature alters the permeation of caffeine, methyl 
paraben and butyl paraben by more than two-fold (F. Akomeah, Nazir, Martin, & Brown, 
2004). 
Generally, two distinct approaches are employed in drug permeation analysis namely, a finite 
and infinite dose approach. The basic difference between the two approaches is such that the 
former requires a certain drug concentration that can be changed and varied according to 
suitability of the intended experiments, while the latter employs a constant concentration 
usually from the saturated form of the drug in question. Another important factor to consider 
is a constant agitation of the fluid in the receptor compartment using a magnetic stirrer at an 
optimum speed, especially when experiments last for many hours. Stirring should be such that 
the speed is not too fast to create a vortex, which may disturb the flow rate, leading to the 
formation of bubbles that can affect the permeation profile. 
If a permeable compound is added to the donor chamber then a steady-state diffusion from the 





molecules from a region of higher concentration to a region of lower concentration through a 
semi-permeable membrane will occur. Hence, the concentration gradient across the membrane 
would be constant or linear. Thus, Equation 1.1 can be re-written as: 
 
    Jss = D 
[𝐶0− 𝐶ℎ]
ℎ
                         Equation 1.2  
Where Jss is the steady state flux, C
o is the initial concentration of permeant on the surface of 
the membrane, (the donor compartment concentration) and Ch is the concentration of permeant 
within the membrane at a certain position, h, i.e. the receiver compartment. These permeant 
concentrations are difficult to ascertain in practical terms, hence a partition coefficient that 
describes the partitioning between the permeant and the aqueous solution is introduced for 
convenience, therefore, concentrations of the aqueous solution in the donor and receiver 
compartments are obtained practically (Avdeef, 2012). Equation 1.2 can therefore be written 
as: 
     Jss = DK 
[𝐶𝐷−𝐶𝑅]
ℎ
            Equation 1.3 
Where K is the introduced membrane partition co-efficient, CD the donor compartment aqueous 
solution concentration and CR the receiver compartment aqueous solution concentration.  
Equation 1.3 can be simplified further considering the fact that the diffusion coefficient (D) is 
still practically difficult to ascertain, hence, the kinetic parameter D, the thermodynamic and 
the membrane thickness parameters K and h respectively, can be combined to give the 
permeability coefficient parameter Kp. The equation can then be written as: 
     Jss = Kp (C





Furthermore, the concentration of the receptor compartment is effectively zero, in comparison 
with the donor compartment. This is practically obtainable if the permeant concentration in the 
receptor compartment does not exceed 10 % of the donor compartment (Moss et al., 2016). 
Hence, Equation 1.4 becomes simplified to: 
     Jss = KpC
D                 Equation 1.5 
Having met the conditions previously highlighted, the permeability coefficient Kp becomes 
experimentally obtainable and provides useful information regarding permeation in topical and 
transdermal drug formulations. The convenience in comparing these experimentally 
determined datasets and existing skin data can be seen further in Flynn’s work, where a 
significant amount of data has been published using this approach (Flynn, 1990). More 
recently, a larger dataset has been collected using this approach which includes (but not limited 
to) the previous dataset of 283 compounds (Baba, Takahara, & Mamitsuka, 2015). 
It is quite important at this juncture to mention some of the specifications for in vitro 
permeation studies according to the European Medicines Agency Guideline (EMA). It 
stipulates that, in vitro permeation analysis is meant to evaluate the permeation of drugs across 
the skin and is not necessarily expected to establish a correlation to that of in vivo permeation.  
Permeation studies allow the use of artificial or synthetic membranes, as well as human skin 
or skin from animals such as rodents, snakes, pigs and other animals. It is expected that when 
using synthetic membrane, information such as membrane thickness, integrity of the membrane 
and at least six repeatable data sets should be provided. The solvent used should be an aqueous 
buffer for water soluble drugs. However, hydroalcoholic media or the use of solubility 






1.2.3.1 Properties of Penetrants 
Having understood to a large extent theory about how the skin works, and the principle that 
tries to explain how permeation of drugs across the skin occurs, another interesting area for 
researchers is physicochemical properties of the permeant when formulating topical drugs. 
From Fick’s law, it became apparent that diffusion coefficient (D) and permeation co-efficient 
(K) need to be appropriately considered, as each factor can influence the overall effect of 
permeation, thus can assist in the design of an appropriate drug candidate. It is also vital to 
establish the main factors that affect skin permeability which are size and shape of the 
permeant, superficial charges, lipophilicity, penetration enhancers, and physical state of the 
skin (Verma, Verma, Blume, & Fahr, 2003), to be able to mitigate them and understand how 
best to predict permeation.  
The physical parameter K, that represents partition co-efficient in this instance the stratum 
corneum, describes the relative concentration of the permeate present in the stratum corneum 
and in the vehicle, at equilibrium. As such, the rate determining state depends largely on the 
solubility of the penetrant in each phase. Since the stratum corneum is mainly a lipophilic 
barrier, molecules with high log P (octanol-water partition co-efficient) values should be able 
to absorb better, thus permeate faster. Yet, compounds with a balanced partition co-efficient of 
approximately one (1), tend to permeate the skin better, compared to compounds with a higher 
value of log P. Examples of such compounds with moderate log P values are nicotine, estrogen, 
scopolamine and nitroglycerin. Even with this empirical data, recent compounds specifically 
designed for TDDS still tend to have lipophilic values that are comparatively low (Y. Chen, 
Quan, Liu, Wang, & Fang, 2014).  
Most topically formulated compounds rely on the theory that the lipid domains between 





lipophilic compounds have greater tendencies to permeate skin. Practical science still 
somewhat suggests that it is not enough to have an affinity to the lipophilic route, but also 
tendencies of partitioning out of this route should also be considered. In essence, the lipophilic 
pathway should serve as a route rather than a rate limiting step. In relation to this , Moss et al 
in 2016 was able to publish a large dataset of compounds that explains how compounds with 
high lipophilic values (log P > 3) exhibit poor clearance from the viable tissues, and suggests 
that compounds with log P values of 1 <  log P > 3, are the most suitable candidates  for topical 
delivery, when considering log P values (Moss et al., 2016). This is to say drugs with log P 
values > 3, would rather stay longer on the lipophilic pathways instead of permeating easily 
via this route. 
However, following the general aqueous state topical compounds are formulated in, it becomes 
necessary for compounds to show some hydrophilic favourability (Malvey et al., 2019) and 
when comparing molecular size, solubility and melting points with regards to TDDS, it is 
considered that an inverse relationship exists between transdermal flux and molecular weight. 
Therefore, since there is fair comparison between molecular weight and size, compounds 
having a smaller molecular size make better candidates. In this case, lipophilic compounds are 
often not favoured given their relatively large molecular size. Moreover, the diffusion co-
efficient is heavily influenced by molecular size and temperature (F. Akomeah et al., 2004; 
Shahzad et al., 2015) with the diffusion co-efficient directly related to an increase in 
temperature and inversely proportional to hydrodynamic radius. This forms the basis of a 
general ceiling of 500 Da for compounds considered as transdermal drug candidates. In 
addition, organic molecules tend to have low relative aqueous solubility at standard 
temperatures and pressures, hence lipophilic solutions also prevail in terms of TDDS, when 





The balance of opinions supported by practical data further points to the necessity of having an 
alternate surrogate skin sample which can mimic the activity of the skin. Furthermore, it could 
provide another perspective for researchers to further understand how the skin works, 
consequently helping to harness the full potential skin has to offer as a route for drug delivery.  
1.2.6. Human tissue 
The use of human skin equivalent models (ex-vivo) obtained from cadavers or cosmetic 
surgery, when used for percutaneous absorption studies, are often considered as the gold 
standard (Elnaggar, El-Massik, & Abdallah, 2011) and a potentially viable alternative to skin. 
However, the skin as a living entity itself is not fully represented when used in this form. 
Furthermore, inconsistencies in uniformity and reproducibility in skin-based membrane 
experiments have been suggested as issues related with such systems (Batheja, Song, Wertz, 
& Michniak-Kohn, 2009). In addition, limited availability of these samples often hinders their 
widespread usage. Even when samples are available, de-freezing and disinfection treatment 
can be problematic too (Abd et al., 2016). Scientists as far back as the 1980’s proposed that not 
only biological tissues with viable cells can effectively predict permeation (Bronaugh, Stewart, 
Congdon, & Giles Jr, 1982). Development of biophysical techniques have also helped in 
amplifying this idea. It is now established and universally accepted that other forms of 
membranes can effectively predict and mimic permeation of the skin without necessarily 
having viable cells. 
However, in trying to address availability concerns posed by human skin, scientists have tried 
to create skin analogues often referred to as the ‘living skin equivalent (LSE)’ model. This 
model comprises of full thickness skin (FTS), split thickness skin (STS), isolated stratum 





in histological studies. In measurement and prediction of permeation analysis, these 
membranes fall short, and considering their relative cost makes them a challenging alternative.  
It is important to note that permeants diffuse the skin via three different routes; the skin 
appendages (hair follicles and sweat glands), the intercellular lipid lamellar within the stratum 
corneum and via keratin bundles, and these routes collectively gives the net amount of drugs 
permeating the skin. Any model that tends to ignore any of these routes, outrightly negates its 
potential of making a viable alternative.  In the LSE model, full thickness skin (FTS), has 
partially separated stratum corneum which gives relatively low permeability results, whereas 
the split thickness skin (STS) lacks appendages such as hair follicles and sweat glands (Godin 
& Touitou, 2007). Other options such as isolated stratum corneum (ISC)  and  heat separated 
epidermis (HtSE) are too fragile to handle and require an underlying support (F. K. Akomeah, 
Martin, & Brown, 2007). Thus, it has been concluded that models such as the LSE model have 
limited use in in vitro permeation studies (Schmook, Meingassner, & Billich, 2001) and (Roy, 
Fujiki, & Fleitman, 1993).  
1.2.7. Animal Tissue 
Another alternative considered is the use of animals, based on their far wider availability 
compared with human tissue. These animals are used in the development of drugs, 
determination of toxicity for compounds destined to be used by humans, and this practice can 
be traced as far back as 500 BC. 
 Most frequently used in TDDS studies are the excised skin from mice, albino rats, pigs, guinea 
pigs and rabbits (Balakrishnan et al., 2009), (Özgüney et al., 2006), (Qvist, Hoeck, Kreilgaard, 
Madsen, & Frokjaer, 2000), (Dalton, Graham, & Jenner, 2015) and (Nicoli, Penna, Padula, 
Colombo, & Santi, 2006). This is largely a general phenomenon, as a similar profile is also 





It is reported that tissues from snakes and fish are also used, but these types of skin samples 
suffer from a relative shortage in availability (Lee, Conradi, & Shanmugasundaram, 2010). 
 
 
Figure 1. 4 Percentage of animals used in the United Kingdom for scientific experiments (3.4 
million) in 2019. 
A vital point of arguments often presented in supporting the use of animals for scientific 
experiments is the area of biomedical research. It is argued that viable cells in the animals helps 
researchers study numerous diseases. The common practice involves inducing these animals 
with artificial diseases and conducting experiments on them. This then allows researchers to 
test a new drug intended to cure the induced disease (Barnard & Kaufman, 1997; Botting & 
Morrison, 1997). However, often times there is one observation per animal, which increases 
the number of animals used for a given set of experiments. During the experiments, the animals 
are often restrained which makes it difficult for animals to escape the pain. Vivisection is 
sometimes employed to induce or infect the animals with desired diseases. Every known human 
disease has been tested on animals and even ‘predictive’ ones are being tried on animals, with 
the aim of quantifying, curing, or discovering a treatment. This is how the animal testing model 





Invasive procedures such as traumatic injuries, burns, social deprivation, force-feeding, 
creating an artificial heart-attack, implanting electrodes in the body to induce brain traumas, 
motion sickness, irregular heart rhythms, migraines, and other environmental manipulations to 
cause distress and other more severe injuries including spinal cord injury and paralysis are all 
part of this practice (Bhanu Prasad, 2016a; Mukerjee, 1997).   
Variation in the biology of animals used for scientific experiments can affect the outcome of 
results, even within animals of the same species. Animals of different development stages, ages 
and sex, can result in immense differences in the outcome of a result. More specifically, in the 
prediction of percutaneous drug delivery, the use of animal tissue results in over-estimation of 
permeability data (Lu, Lee, & Rao, 1992),  and difficulty in the preparation set-up. Mice skin 
for instance is thinner than human skin, and most of the animals used have more hair follicles 
than humans, thereby increasing the issues for percutaneous predictions (Geusens et al., 2011). 
It is reported that for skin permeation experiments there is an increase of 3-5 folds in 
permeation values when using rabbit skin as the membrane (Chowhan & Pritchard, 1978), 
about 11 folds with rat skin (Van Ravenzwaay & Leibold, 2004), and close to 100 folds with 
nude mouse (Lu et al., 1992), making it increasingly difficult to compare the data with that of 
humans.  
In addition, over the last decade, there has been an increase in the laws and regulations 
regarding the use of animal testing. Notable amongst the laws are the Registration, Evaluation, 
Authorisation and Restriction of Chemicals (REACH), which was signed on the 1st of June 
2007, which promotes the use of alternative methods in data analysis and prediction such as 
using quantitative structure-activity relationship models (QSARs). The law also requires 
manufacturers of certain materials to submit all dossiers with relevant data including skin 





Chemical Agency (ECHA) and the Health and Safety Executive (HSE) have all restricted and 
addressed various ethical and safety issues about the use of animal models. There is also a 
global debate in using animals for cosmetic testing (Y. Wang, Zhao, & Song, 2020). For 
example, there is a complete ban for animal-cosmeceutical practices in places such as the EU 
(cosmetic directive 76/768/EEC), i.e.  all of these factors pose a serious constraint in the use of 
animal testing (Sreedhar, Manjula, Pise, Pise, & Ligade, 2020). 
The use of animals for scientific purposes often boils down to an ethical question and the 
question of whether it works. It is largely agreed that without animal testing most of the 
successful drugs and advancements we have seen medically wouldn’t have been possible. 
However, progressive scientists argue that there is the need for a rise in efforts from a data 
quality and ethical perspective to find alternative models, and minimise the many problems 
associated with this aged practice. 
1.2.8. Alternative models 
Alternatives to human and animal testing are largely based on biochemical assays, in-vitro 
analysis, and computational models which are based on algorithms. These alternatives are 
technically more robust, sophisticated, easily maintained and controlled, more so than the 
classical methods of human and animal tests. In addition, recent research is increasingly 
focusing on developing models that can mimic the living system, which are less expensive and 
experimentally efficient and sustainable. Moreover, regulators and generics are fast moving 
towards accepting some of these in-vitro techniques. Recently, the Organisation for Economic 
co-operation and Development (OECD) has accepted cell culture models for their usage in ex-





Other remarkable milestones achieved with these alternate methods includes the development 
of human brain cells (microbrain) which can be used to study brain tumours, as well as the 
development of artificial skin (Epiderm) and bone marrow (Bhanu Prasad, 2016b). 
Institutes including inter-disciplinary researchers are currently working on a distinct field 
referred to as ‘lab on chip’. This type of research is primarily aimed at recapitulating the 
physiological functions of living organs, such as lungs, hearts, skin and intestine. These organs 
on a chip (Figure 1.5) could one day mimic functions of traditional organs. Because these 
devices are made up of translucent flexible polymers that contain hollow microfluidic channels 








Figure 1. 5 An illustration of some developed ‘Organ on a chip ‘systems. 
In general, given the development of biophysical techniques, it is no longer acceptable to use 
animals for purposes of studying what happens within the body. Advanced X-rays, MRI and 
CAT scans all allow researchers to look inside the human body in real time (Bhanu Prasad, 
2016a).  





1.2.9. Cell culture 
Success stories have been recorded regarding acceptance of cell culture models in place of 
laboratory animals as it relates to this study. Notable amongst these models are reconstructed 
human epidermis (RHE) and some living skin equivalents (LSEs). These models try to mimic 
the human skin structure, for example, RHE consists of a three-dimensional framework, which 
is grown from keratinocytes and possesses stratum corneum equivalent on its surface. 
These models have proven promising especially in histological studies and related research 
areas (Hausmann et al., 2019). Despite promising features of these models, barrier functions 
and by extension prediction of percutaneous absorption crucial to this study, have been found 
to have limitations. For instance, these skin equivalent models over-estimated permeation when 
compared with isolated human tissue (Batheja et al., 2009). Similar findings were reported by 
(Küchler, Strüver, Friess, & toxicology, 2013), who attributed these limitations to immaturity 
of the stratum corneum. Poor reproducibility, its delicate nature, un-ease of handling, and high 
cost has contributed to limiting its widespread use and acceptance, especially for use in 
percutaneous predictions.  
 
1.2.10. QSPR 
Another major alternative to the use of skin samples and in vivo analysis in research is computer 
modelling. This area of research has also opened new areas, with the advent of neural network 
modelling and non-invasive imaging. In some cases, more indirectly, the internet has allowed 
the reduction of duplicate animal testing via the pooling of data. 
Understanding the relationships between physicochemical properties of permeant and their 
extent of permeation when used as active pharmaceutical ingredients (APIs) is an area of 





extensive work in related areas. Derived mathematical relationships have become an important 
aspect in this field. Pioneering work by Potts and Guy (R.O. Potts & P.R. Guy, 1992), has been 
described as one of the most widely accepted models. Using data from Flynn’s work (Flynn, 
1990), the authors were able to relate the log Ko/w  partition co-efficient, permeability co-
efficient Kp, and molecular weight of different drugs. Although the data used was from Flynn’s 
dataset, the model has stood the test of time, as more recent QSPR models also use the same 
empirical data and principle of steady-state transport across excised human epidermis, and as 
such their main output theme remains the prediction of a human skin permeability co-efficient 
Kp (Pecoraro et al., 2019). 
Potts and Guy built their model with the assumption that, despite the stratum corneum being 
the rate limiting barrier of the skin, it is considered to have highly organised lipids, hence, 
diffusion can occur by sink conditions, which correlates to the steady state condition described 
by Fick’s law. Employing a logarithmic form of Fick’s equation, and assuming an exponential 
relationship between molecular weight and diffusivity (free-volume theory) (Potts & Guy, 
1992) provided the following model:  
   Log Kp = -6.3 + 0.71 log KOW – 0.0061 MW        Equation 1.6
          
The work was based on using the ‘bricks and mortar’ concept, as the appendageal pathway was 
neglected. This model explains the relationship between highly hydrophilic compounds and 
their low molecular weights, which translates to their low diffusivity via the lipid lamellae. The 
simplicity of this model coupled with its correlation value (R2 = 0.86), in relation to the 
approximately 90 compounds it was developed upon, makes it the most frequent model cited 





It is clear that the Potts and Guy model neglected the appendageal route, whereas work by 
Mitragotri proposed four different routes via the stratum corneum. These routes are diffusion 
through the lipid lamellae, along the lipid lamellae, through defects in the stratum corneum and 
diffusion via the appendages. The latter of which being the most relevant route, (which was 
considered not relevant in the Potts and Guy model) and also divided properties of the permeant 
into low and high molecular weight, hydrophobic and hydrophilic drugs (Mitragotri et al., 
2011) and (Mitragotri, 2003).  
Consequently, Mitragotri was able to devise the following model: 
Log Kp = -2.39 + 0.74 log KOW - 0.0091 MW                                Equation 1.7 
This stark difference between the Potts and Guy model alongside Mitragotri’s model, presents 
an interesting challenge in the QSPR approach. Moss et al observed in their findings while 
testing the Potts and Guy model that steroids are frequent outliers. They further suggest that 
data used in the study was extracted from a single data source, more challenging is how it 
displays poor compatibility with recent data. The authors proceeded in creating their model (n 
=116 compounds), incorporating steroidal compounds and other therapeutic classes (Moss et 
al., 2016). 
 In theory, it appears that predictive models could address all the problems that relate to ethical 
issues, labour-intensiveness, cost and perhaps time-consuming problems associated with 
current systems. However, the lack of a universal model that can take into consideration all of 
the potential routes of drug permeation via the skin, stands out to be a limiting factor for all 
predictive models presented to date. Moreover, variability in changes any model is built upon 
could render the model inefficient. More puzzling is the complexities for newly developed 
drugs, hence some of these models have evidently failed to provide an effective tool that will 





1.2.12. Poly(dimethylsiloxane)  
Desirable properties of poly(dimethylsiloxane) (PDMS), as a silicon polymeric membrane, 
such as simplicity in usage, increased obtainability, susceptibility to surface modification and 
reduced cost (S.-F. Ng et al., 2012) has led to the choice of PDMS for this study. Additionally, 
PDMS addresses most of the major challenges encountered with the use of human or animal 
skin in permeation analysis, including uniformity, stability, ease of handling, sufficiency for 
large scale studies, ethical and legal issues. In addition, certain properties PDMS membrane 
offers makes it even more attractive for utilisation, particularly as a substitute for biological 
tissues in permeation analysis. While the advantages are clear, it is imperative to highlight some 
of the challenges (and numerous modifications recently developed to overcome such 
challenges) encountered in tailor-fitting the membrane to the desired outcome. 
As far back as the early 1940’s, polyorganosiloxanes, a family of compounds to which PDMS 
belongs, have been produced on an industrial scale (via Muller–Rochow direct synthesis) 
(Pouget et al., 2010). The overall estimation of silicon based materials available as far back as 
2002 was estimated to be over 2 million tonnes, and one of the major reasons for the high 
production and demand of silicon based polymers is a consequence of their un-paralleled 
thermal stability and flexibility properties, compared with other polymer membranes (Owen & 
Dvornic, 2012; Pouget et al., 2010). Most of these properties are largely attributed to the Si-O-
Si backbone of these polymers. PDMS has a Si-O-Si bond angle of 140° (Hurd, 1946) 
exhibiting a certain orientation in space and has a glass transition temperature of -123 °C (Tan 
& Rodrigue, 2019) due to its molecular backbone orientation, which allows a level of torsional 
motion. It also has low intermolecular forces, and therefore a large molar volume of 75.5 
cm3mol-1. The low cohesion energy, poor solubility and surface energy can all be attributed to 
this low intermolecular force. However, the value of the Si-O-Si bond is high (110 kCal mol-





bonds, which explains the excellent thermal stability of the polymer (Hurd, 1946). Methyl 
groups present on the membrane surface are largely responsible for the hydrophobic nature of 
the membrane.  
 




Figure 1. 6 General structure of poly(dimethylsiloxane), also known as PDMS. 
Other remarkable properties of the membrane include: gas permeability making it transparent 
to visible and UV light (the methyl groups do not absorb radiation above 300 nm) (Pouget et 
al., 2010), relative environmental friendliness (it does not bio-accumulate), low-cost and non-
toxicity (Roychowdhury, Cushman, Synowicki, & Linford, 2018; Tan & Rodrigue, 2019; 
Tibbe et al., 2018). These properties, amongst others too numerous to mention, gives PDMS 
advantages over other polymeric membranes, making it the most commonly used polymer 
among the polyorganosiloxanes (Pang, Koh, Li, & He, 2020). These desirable features also 
facilitate using it for biological mimic functions, such as a human skin mimic.  
For more than sixty years, there has been considerable research to enhance, or incorporate, the 
use of polymeric membranes for drug delivery purposes (Arora & Mukherjee, 2002; Quinn, 
Bonham, Hughes, & Donnelly, 2015; Yiyun et al., 2007). However, in the last decade there has 
been an increase in PDMS-biological research. For example, its optical transparency and gas 





as well as discreet oxygen sensors (Jiang, Thomas, Forry, DeVoe, & Raghavan, 2012). More 
recently, powdered PDMS has been utilised for the delivery of genes into cultured animals 
(López, Rubio, Sadek, & Vega, 2020) and as mimics in fluids analogous to blood particulates 
(Pinho, Muñoz-Sánchez, Anes, Vega, & Lima, 2019). Following the same route, the selectivity, 
stability and very low permeation profile of the membrane prompted scientists to consider it as 
a potential candidate to mimic the barrier function of human stratum corneum. Interestingly, 
its ability to adhere to modifications also makes it an outstanding candidate for such studies.  
It is also reported that tailored properties can be achieved by the judicious choice of the 
chemical substitute, including skin-like properties. A plethora of data have shown how PDMS 
possesses some intrinsic flexibilities, where modifications on the membrane can lead to an 
overall effect on how it works (Lei et al., 2017; Lin, Zhao, & Yan, 2016; Shahsavan, Quinn, 
d’Eon, & Zhao, 2015; Shin, Kim, & Hong, 2018; Sondhi, Hwangbo, Yoon, Nishida, & Fan, 
2018; Trantidou, Elani, Parsons, & Ces, 2017).  
Over the last decade, a plethora of research has been published that involves modifications 
carried out on the membrane which subsequently alters the permeation profile compared with 
the un-modified form of the membrane. For example, a recent study has shown how the use of 
plasma treated PDMS membrane resulted in significant changes in the permeation profiles of 
some sample drugs when compared with permeation profiles from an un-modified form of the 
membrane (Waters, Finch, Bhuiyan, Hemming, & Mitchell, 2017). Such studies further 
highlight the possibility of tailoring the membrane into a desired outcome and how surface 
treatment can affect the membrane permeation profile. 
Table 1 is a summary of vital studies carried out that have considered PDMS as a potential 
alternative to skin. Relevant findings related to percutaneous absorption, their limitations and 
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Based on the findings presented in Table 1, along with some other examples that can be found 
in literature, it is fair to say that PDMS membrane has been receiving immense consideration 
over the past few years as a potential alternative to skin for permeation analysis. However, 
some scientists still show reservations in accepting artificial membranes, proposing that it will 
not successfully model the lipid perturbation effects undergone by biological tissues (Küchler, 
Strüver, & Friess, 2013). A comparison of PDMS with skin equivalent models is summarised 
in Table 2 which tries to compare the membrane advantages over these biological models and 
how these advantages point to the need to actually consider the membrane as an alternative. 
Table 1. 2 Comparative description between PDMS membrane and skin equivalent models. 
Skin model Advantages Limitations 
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-Availability and storage 
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-Variance resulting from 
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-Over prediction of percutaneous 
absorption 
 
1.2.10.2 Broad classification in modifications of PDMS. 
A brief overview of the broad classification on the general methods employed in modification 





Table 1. 3 A summary of the main techniques employed for PDMS modifications.  
Main 
Techniques 










This method of modification is mostly a physiosorbed process that 
relies on interactions of materials chiefly by the principle of weak 
attractions such as Van der Waal forces. A solution-based approach is 
mostly used, that comprises the membrane and a desired solvent 
solution. Amphiphilic groups from the selected solvent, interacts with 
PDMS membrane and attach their lipophilic group on the hydrophobic 
surface of the membrane, thereby altering its surface chemistry. These 
surfactants referred to as ‘dynamic modifiers’ are utilised in different 
ways ranging from the exposure of the already prepared membrane in 
a solution containing the surfactants (A.-J. Wang, Xu, & Chen, 2006), 
to direct introduction of the surfactants in the pre-cured monomer 
mixture during the polymer synthesis. (Holczer & Fürjes, 2017).  
Significant changes in surface chemistry of the 
membrane have been observed following this 
type of modification, using water contact angle 
analysis. It is reported that a significant 
reduction in water contact angle ( from 110 ℃ 
to 23 ℃ ) was observed (Madadi & Casals-
Terré, 2013), in the modified form of the 
membrane, following this process. 
It is also reported that this surface change can 
affect the overall permeation profiles of these 
membranes when used in permeation analysis. 
(Bhuiyan & Waters, 2017).  
 
It is in-expensive and 
effective process.  In 
some instances, the 
principles of this 
modification process 
gives similar 
outcomes to the 
plasma modification 
process which is a 
more expensive 
technique (Madadi & 
Casals-Terré, 2013) 
It is superficial and mostly 
short term. 
Depletion of the modifiers 
can easily occur when such 
membranes are utilised for 
permeation analysis. The 
modifiers simply diffuse 
into the aqueous solution, 
thus exposing the 
membrane back to its 







This process is more of a chemisorbed process. It involves more 
stronger bonds, which can bring about a more robust change and effect 
almost at a molecular level. The process largely oxidises the surface 
methyl groups of this membrane, thereby altering its chemistry. It is 
more robust in terms of wettability and reactivity of the membrane, and 
also more stable compared to dynamic modification. Example of such 
process involves the use of Piranha solution (H2O2 / H2SO4) (Maji, 
Lahiri, & Das, 2012), UV/O3 treatment, and plasma treatment.  
This process largely results in the cleavage of 
the alkoxysilane group (Si-CH3), and 
formation of a silanol group (Si-OH) (I.-J. 
Chen & Lindner, 2007). This change has also 
been reported to alter the permeation profile of 
PDMS membranes (Waters et al., 2017) 
Relatively more 
stable, compared to 
membranes modified 
using the dynamic 
method.  
Different chemical entities 
are utilised in this method, 
which could be corrosive 
and has a high risk. Some of 
the techniques employed 
are expensive and requires 






This process is basically an extension of the ‘surface oxidation’ 
process. It involves attaching various chemical functionalities on the 
already oxidised membrane surface. Organosilanes have received a lot 
of attention for such purpose. Largely attributed to their moderate 
reaction protocols and in-expensive nature (Chuah, Kuddannaya, Lee, 
Zhang, & Kang, 2015)  
The process provides a wide array of 
modification possibilities thus substantive 
literature have reported membranes that have 
undergone this type of modification 
It is comparatively in-




application in in vitro 
analysis, limited attempts 
have been made to modify 






1.3. Research Aim and Objectives 
The aim of this research is to chemically modify poly(dimethylsiloxane) polymer membrane in 
order to effectively mimic surface activity of the skin in permeation analysis, consequently, 
addressing the challenges often associated with the use of skin in transdermal drug delivery 
processes. This aim is set to be achieved according to the following set of objectives: 
 
❖ To identify and acknowledge various methods and works previously employed on 
the membrane, in an attempt to address and bridge the research aim, thereby 
constructively identifying existing gaps. 
❖ To identify, study and apply different functionalities that are compatible with 
PDMS membrane and are capable of driving effects strong enough to result in 
permeation profile changes 
❖ To employ a range of analytical techniques to characterise the newly developed 
membranes, hence provide an avenue for replication of the process 
❖ To compare obtained data from modified membranes with human skin data from 
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The aim of this project was to experimentally modify and characterise poly(dimethysiloxane) 
PDMS membrane. To achieve this a theoretical background in relevant topics was acquired, as 
highlighted in Chapter 1. This background knowledge was itemised to include chemical 
composition and description of the membrane surface, methods involved in altering the surface 
and possible re-orientation of these surface elements that may occur as a result of different 
modifications.   
This chapter highlights materials, chemicals and methodologies needed to achieve the research 
aim. Differences and similarities in the methodology used in comparison with existing literature 
are also described. Pre-experimental work carried out, mainly in standardising model drugs and 
understanding their chemistry, to permit comparative analysis with established standards are also 
highlighted. Design and optimisation processes, in terms of permeation analysis, is aimed to mimic 
in-vivo scenarios, are also described.  
In Table 2.1 and 2.2, a full list of materials and chemicals employed in this research are 
highlighted. The purpose of these materials and their overall importance in terms of the 
experimental procedures is also described. Table 2.3 provides a detailed description of the model 
drugs and other related compounds used, their physicochemical properties such as molecular 








2.2. Chemicals and Materials 
A detailed list of chemicals and materials used in this research are presented in Table 2.1 and 2.2. 





Table 2. 1 Description of materials used in this study 
Materials Symbol Man./ 
Supplier 
Grade/Model/Specifications Note 
SilatosTM silicon sheeting N/A Silex, Hampshire, UK. Dimension 150 x 200 x 0.3 mm 
This was used as received for normal 
membrane processes and was subjectively 
modified, which where applicable are 
reported as modified membranes. 
Tempered clear glass with 
laminated surface 
N/A NA Thickness: 6mm 
It was used as a support to cut the 
membrane into required pieces and had 
good adhesion to the membrane surface. 
Re-usable scalpel blades N/A Swann-Morton N/A 
Was used to cut the membrane into 
required pieces. 
pH/Temperature meter N/A Jenway instruments 3510 pH Meter 
It was used to measure pH of solutions 
and for temperature measurement, which 
was mainly as a control in permeation 
analysis 
Oven N/A Thermo scientific Fisherbrand  
This was used in drying samples and 
activating the membrane in some 
instances 
Magnetic stirrer N/A Stuart Hot Stirrer N/A N/A 
Plasma generating system HPT-100 Henniker plasma, UK HPT-100 
Used for preliminary membrane surface 
oxidation, optimised to operate at 100 W 





Table 2. 2 Description of chemicals used in this study 










These were used as purchased and were 





Hydrogen chloride HCl AR grade 99% 
These were used primarily to adjust the 
pH of solutions as appropriate. 























These were used as precursors in 
modification processes. 
Dimethyphenylsilanol C8H12OSi - 
Pentan-1,5-diol C5H12O2  
Tertbutyldimethylphenylsilanol C6H15SiOH 99% 
(Perfluorophenyl)silanol   
Poly(dimethylsiloxane)-poly(ethylene 















Used for preparations of solutions, 













b Abbreviation CAF a 
 




Grade used ≥ 99.5 % 
Molecular Weight 194.19 g mol-1 
c Log P -0.07 
Charge Cationic  
d pKa 10.4 
Λmax 271 nm 
d BCS Class I 
Lidocaine  





Grade ≥ 99 % 
Molecular Weight 234.34 g mol-1 
c Log P 2.44 
Charge Cationic  
d pKa 7.8 
Λmax 230 nm 





Benzoic acid  
b Abbreviation BZA a 
 
                      
 
 
                 
 
Suppliers Sigma Aldrich 
Grade ≥ 99 % 
Molecular Weight 122.12 g mol-1 
c Log P 1.89 
Charge Anionic 
d pKa 4.2 
Λmax 228 nm 
d BCS Class II 
Ethyl 4-hydroxybenzoate  







Grade ≥ 99 % 
Molecular Weight 166.17 g mol-1 
c Log P 2.47 
Charge Anionic  
d pKa 8.34 pc 
Λmax 254 nm 

















Grade ≥ 99 % 
Molecular Weight 165.19 g mol-1 
c Log P 1.86 
Charge Cationic  
d pKa 2.51  
Λmax 287 nm 
d BCS Class II 
Salicylic acid  
b Abbreviation SAL  a  
 
                         
 
                   
Suppliers Sigma-
Aldrich 
Grade ≥ 99.5 % 
Molecular Weight 138.12 g mol-1 
c Log P 2.26 
Charge Anionic  
d pKa 2.71 
Λmax 234 nm 
















         
Suppliers Tokyo Chemical Ind 
Grade ≥ 99 % 
Molecular Weight 206.28 g mol-1 
c Log P 3.97 
Charge Anionic  
d pKa 4.85 
Λmax 221 nm 
d BCS Class II 
Diclofenac  
b Abbreviation DCF a 
 
 
Suppliers Tokyo Chemical Ind 
Grade ≥ 99 % 
Molecular Weight 296.15 gmol-1 
c Log P 4.51 
Charge Anionic/Cationic  
d pKa 4.13 
Λmax 275 nm 














b Abbreviation KPF a 
 
 
Suppliers Fluorochem Ltd 
Grade ≥ 99 % 
Molecular Weight 254.28 g mol-1 
c Log P 3.12 
Charge Anionic 
d pKa 3.88 
Λmax 261 nm 
d BCS Class II 
Antipyrine  





Grade ≥ 98 % 
Molecular Weight 188.22 g mol-1 
c Log P 0.38 
Charge Cationic 
d pKa 1.45 
Λmax 242 nm 



















Suppliers Tokyo Chemical 
Ind 
Grade ≥ 98 % 
Molecular Weight 264.36 g mol-1 
c Log P 2.79 
Charge Cation 
d pKa 8.42 
Λmax 310 nm 
d BCS Class II 
Procaine  





Grade ≥ 97 % 
Molecular Weight 236.31 g mol-1 
c Log P 2.14 
Charge Cation 
d pKa 8.95 
Λmax 290 nm 
















Suppliers Tokyo Chemical 
Ind 
Grade ≥ 99.5 % 
Molecular Weight 278.3 g mol-1 
c Log P 0.32 
Charge Cation 
d pKa 19.64 
Λmax 274 nm 
d BCS Class III 
 
*a- Sited from PubChem and drawn with ChemDraw Application 
*b- Locally adopted for purposes of this study 
*c- Adopted from Drugbank 




2.3.1. Analytical and Experimental Procedures 
In this section, laboratory procedures and spectroscopic techniques used are broadly 
highlighted. Their principles and how they relate to this work are also described. 
Poly(dimethylsiloxane) PDMS silicon membrane with a thickness of 0.3 mm was used 
throughout this study and is referred to as standard membrane. Its selective permeability is 
studied in this research, which forms the main basis for its consideration to replace skin in 
permeation analysis. In trying to address issues such as the leaching effect and reduced 
permeability associated with the membrane, a variety of modification processes were carried 






chemical modifications, sometimes their reactivity is influenced by the nature of their branch 
chains or groups (Botvay, Máthé, & Pöppl, 1999). In contrast, PDMS has straight chains, with 
a very stable silicon-oxygen bond, which makes it comparatively more difficult to chemically 
modify. Nonetheless, the work presented in this thesis is a series of attempts made to effectively 
modify the membrane, and this chapter reports the analytical techniques employed to help 
achieve this aim. 
2.3.1.1 Atmospheric Pressure Nonthermal Air Plasma Treatment of 
Poly(dimethysiloxane) 
For many years, successes have been recorded in using solventless processes such as plasma, 
corona, flame, x-ray treatments, electrons or ion beams to modify polymer surfaces (Chan, Ko, 
& Hiraoka, 1996). These solventless treated membranes have been applied successfully to 
serve as adhesives, in microfluidic devices, biomaterials or as coatings in some specialised 
materials. In general, certain surface properties such as crosslinking density, conductivity, 
lubricity, hydrophilicity, increased reactivity and roughness have been altered or improved as 
a result of such surface treatments. This study is interested in these solventless methods to help 
activate the inert surface of PDMS membrane, thereby making it susceptible for chemical 
reactions, without altering its bulk properties or compromising integrity.  
Polyethylene, for example, which is used in huge quantities in industry to make films for 
packaging, due to its excellent mechanical properties, has a major problem with bondability, 
and this is due to its inertness and hydrophobic nature. To overcome this problem, oxygen 
plasma treatment is employed to increase its hydrophilicity, consequently addressing the 
bondability problem.  
However, a more delicate and well-crafted method needs to be adopted in application of these 
processes especially when the membranes are intended to be used as biomaterials, such as the 





type of reaction gas employed, depth of the treatment, mechanical strength of the material 
involved and likely interactions that may occur between functional groups of the material and 
reactor gas must be carefully analysed. In biopharmaceutical areas, plasma treatment has been 
used to modify polymer membranes for various applications such as contact lenses, catheters, 
and dialysis membranes.  
The treatment performed in this study was carried-out using air-plasma as the process gas in 
the reactor and was achieved using a benchtop Henniker Plasma machine (HPT-100), at a 
power of 100 W, 68 mbar and flow rate of 8 standard cubic centimeters per minute (SCCM). 
A treatment time of 90 seconds was used throughout the process, which was selected based 
upon an optimisation study carried out (data presented in chapter 3). It was realised that 
treatments above 90 seconds affected integrity of the membrane, making it not suitable for this 
study. Treatments were only undertaken on a single side of the membranes, as only 
modification on the surface directly in contact with drug was relevant in this study. Pieces of 
the membranes were cut into square forms sufficient enough to cover the diffusion area of the 
diffusion cell (~ 0.54 cm 2). The top right corner of the square shaped membranes that were 
cut, were marked, making it possible to identify plasma treated side, when used for further 
analysis. It is considered a pre-treatment method in this research; therefore, it was employed 
solely to replace PDMS surface methyl groups with hydroxyl groups, thereby forming a 
plasma-treated oxidised membrane, more susceptible for future chemical modifications.  







Figure 2. 1 Schematic representation of a typical Plasma generator 
Oxygen containing plasma is widely employed for the surface oxidation of PDMS (Gunda, 
Singh, Norman, Kaur, & Mitra, 2014), however, it is known that oxygen species present in the 
reactor chamber can interact with the polymeric material to produce functional groups (Nehra, 
Kumar, & Dwivedi, 2008) such as C-O, C=O, O-C=O, C-O-O and CO3 bonds at the membrane 
surface. Additionally, there is the likelihood of etching the polymer substrate, thereby giving 
rise to reactive volatile reaction products (Chan et al., 1996). These factors deemed this form 
of surface treatment unsuitable in this study.  
Generally, nitrogen containing plasma is widely used to improve wettability and 
biocompatibility, whereas halogen containing plasmas (especially fluorine and chlorine) are 
largely used to promote etching in polymeric membranes. Air plasma treatment on the other 
hand, provides an easier and inexpensive alternative. This latter process operates using a similar 
mechanism with that employed using oxygen-based treatment. Energy from the plasma extracts 
hydrogen from methyl groups present on the membrane surface, thereby leaving an unstable 
methylene group (-CH2) on the surface. The hydrogen removed further reacts with process air 





group formed, attacks and displaces the unstable methylene group that was left on the 
membrane. Consequently, a hydrolysed membrane surface can be achieved as a result of the 
plasma treatment. Practically, the hydrolysed surface becomes more suitable for further 
treatment, due to an increase in surface tension (Bodas, Khan-Malek, & Chemical, 2007), 
(Zhou, Ellis, & Voelcker, 2010) , (Goda, Konno, Takai, Moro, & Ishihara, 2006) .  
The effectiveness of this process, alongside its ease, has attracted a lot of interest and 
consideration. The process (air plasma treatment of PDMS) is reported to be used as a pre-
requisite in the formation of poly(vinylalcohol) coatings (Li, Wang, & Shen, 2012). It is also 
employed in the field of microfluidic devices (Sharma, Dhayal, Shivaprasad, & Jain, 2007), 
tissue engineering (Leclerc, Duval, Pezron, & Nadaud, 2009), biomolecule immobilisation 
(Hu, Ma, Zhang, & Wang, 2014) and lipid bilayer support systems (Kim & Jeong, 2011). More 
recently, in an attempt to modify PDMS membrane as an artificial skin mimic, the use of air 
plasma treatment has also been reported (Waters et al., 2017). The overall effect on the 
membrane, and how this change can contribute to altering drug permeation profiles through 
this membrane was also reported. 
In addition to available literature, storage conditions and environmental effects that may 
contribute to leaching and an aging effect (reported problems often associated with this 
membrane), were carefully considered, monitored, reported, and controlled in this work. 
2.3.1.2 Scanning Electron Microscopy  
Scanning Electron Microscopy (SEM) is primarily a spectroscopic technique that uses a beam 
of electrons to scan the surface of materials, thereby, creating a 3-dimensional image of the 
material. The basic set-up of SEM involves a light source, a monochromator and lenses to focus 
the electron beam. Hence, a typical SEM has a fine beam of electrons generated by heating a 





The principle of this technique is such that electron beams are accelerated towards an anode 
and focused using condensed lenses onto a very fine spot on the material, deflected with the 
help of the lenses to scan and create a surface image of the sample material. 
When the electron beam hits the surface of the material, a variety of signals are generated as a 
result of interactions between the electron beam and atoms of the materials. These signals are 
mainly: 
• Transmitted electrons (beam that passed through the sample) 
• Secondary electrons (electrons obtained from the material itself) 
• Backscattered electrons (electrons generated from interaction with nuclei of the atom 
in the material).  
Other signals generated includes X-rays and heat, as summarised in Figure 2.2. 
 
 
Figure 2. 2 Typical Incident beam interactions with sample material in SEM analysis, adapted 






Secondary electrons (SE) are released from the surface of the material to give a high-resolution 
image which is readily interpretable, and this is because of the small depth of penetration 
associated with this interaction. Back scattering electrons (BSE) on the other hand, are primary 
beam electrons reflected from atoms of the sample. The BSE give us information about 
different chemical phases in the sample, and their image resolution is lower compared to that 
obtained from SE, this phenomenon is associated with depth of penetration in the BSE. X-rays 
are produced as a result of in-elastic interactions between the primary beam and atoms of the 
sample material. The interaction results in shell transition which causes the emission of X-rays. 
The emitted X-rays have an energy characteristic that matches that of the parent, therefore, 
measurement and detection of these X-rays provides quantitative and qualitative analysis of 
the sample material, in an analysis referred to as elemental diffraction analysis (EDX) and can 
have a sampling depth of 1-2 microns. 
In SEM analysis there is a continuous flow of electrons, which are deposited on the surface of 
the sample material. This may cause a reduction in image resolution. In inorganic samples, the 
SEM process can result in accumulation of charged materials on the surface without discharge 
which can also contribute to a reduction of the image quality. All these problems are overcome 
by coating the sample material with gold (as in the case of this study) or carbon. However, this 
process can cause obscurity of some materials due to possible electric field build-up in between 
the material surface and the coated layer.  
In this research, SEM analysis was performed using a 6060LV JEOL SEM. Prior to the 
analysis, the non-metallic nature of the unmodified, plasma treated, and modified membranes 
made it necessary to coat them for effective conductivity using an 80/20 percent gold/palladium 
sputter coater, and the process was mostly for 40 seconds, using a quorum technologies SC7720 





stage distance of 15 mm for effective focus, and an acceleration voltage of 20 kV, for cross 
section observation.   
2.3.1.3 Water Contact Angle analysis  
Water contact angle (WCA) analysis is a key analysis in this project, as it informs changes that 
have occurred on the membrane surface in relation to its hydrophilicity. Static contact angle is 
defined as the measurable angle (0 – 180 ⁰) that a liquid form when in contact with solid 
materials. Young’s equation (Equation 2.1) tries to describe the contact angle of a liquid on a 
flat-homogeneous solid surface, by relating the surface tension with: 
• the solid-vapor interface (𝛾𝑠𝑣),  
• the solid-liquid interface (𝛾𝑠𝑙) and  
• the liquid-vapor interface (𝛾𝑙𝑣).  
Hydrophilic surfaces have static contact angles in the range of 0 ˚- 90 ˚, while hydrophobic 
surfaces display static contact angles between 90 ˚ and 180 ˚. Surfaces with contact angles 
greater than 150 ˚ are considered super-hydrophobic (Ramirez-Canon, Miles, Cameron, & 
Mattia, 2013). 
     Cos θ =  
𝛾𝑠𝑣−𝛾𝑠𝑙 
𝛾𝑙𝑣
        Equation 2.1 
 
Where 𝛾𝑠𝑣 represents solid-vapor interface, 𝛾𝑠𝑙 solid-liquid interface, 𝛾𝑙𝑣 liquid-vapor interface 
and Cos θ = measured contact angle. 
Young’s equation depicted in Equation 2.1, also tries to explain behaviours of liquid on solid 
surfaces in relation to their contact angles. It describes that when 𝛾𝑠𝑣 = 𝛾𝑠𝑙 then an angle of 90 





In this study, static contact angle (SCA) measurement (1 µL drop size) was used to analyse 
hydrophilicity behaviours between various types of modified PDMS membranes. Analysis was 
carried out using a Kruss, Germany, machine equipped with an optical contact angle device, 
and the process was carried out using an automated dosing system, controlled from a computer 
operating dispensing syringe and a remote-controlled movable stage. The sessile method in air 
at room temperature with ultrapure water was used as the probe liquid. All measurements were 
obtained after three different point measurements within each membrane, with an error of ± 2 
⁰. In this study, super hydrophobic PDMS membrane showed a drastic change with 
characteristics of a hydrophilic membrane.  
2.3.1.4 Ultraviolet – visible (UV - vis) spectrophotometry 
UV-vis spectrophotometry was used to quantify the concentration of model compounds 
following permeation analysis. 
This spectroscopic analysis uses a spectrometer that produces an incident light of a selected 
wavelength, followed by a photometer to measure the intensity of the light. In-between the 
light source and the photometer is where the cuvette (where the sample is placed) is positioned. 
The resultant intensity captured by the photometer delivers a signalled voltage on to a display 
device. The intensity of the signal displayed is an objective parameter resulting from net change 
of light intensity passing through the liquid sample in the cuvette. Therefore, as the 
concentration of the liquid sample changes, so does the amount of light absorbed by the liquid, 
thus resulting in changes in the signal displayed (Sommer, 2012).  
A UV-visible spectrophotometer uses a light source usually from a tungsten lamp, which 
generates the visible region of the spectrum and a hydrogen or deuterium lamp to form the 
ultraviolet wavelengths. The ultraviolet region has a wavelength range of 200 – 400 nm and 





scattered or absorbed by atoms or molecules of substance present in the sample. Absorption 
spectra is achieved due to an energy transition between the bonding and antibonding outer 
electrons of the molecule. Therefore, since the absorption spectra is from 200 – 800 nm, it is 
not advisable to use solvents with very strong absorptions such as most organic solvents in 
sample preparations. Usually water, ethanol and mild buffers are used as reference solutions 
for this type of analysis. 
Application of this spectroscopic technique to quantify the concentration of a substance in 
solution by means of its light absorption at appropriate wavelength is conceptualised using the 
Beer-Lambert law, which states that; when monochromatic light of a specific wavelength 
passes through a solution, there is usually a quantitative relationship between the solute 
concentration and intensity of the transmitted light (Commoner & Lipkin, 1949).  
     I = Io ∗ 10
−kcl    Equation 2.2  
Where 𝐼𝑜 (cm
2) = intensity of transmitted light using pure solvent, I (cm2) = intensity of 
transmitted light when a coloured compound is added, and l = distance of light travel through 
the solution, in a concentration c, and at a constant k. 
However, since the light path (l) in a UV – visible set-up remains constant, Equation 2.2 can 
be re-written as  
     
I
Io
 = 10−kc = T     Equation 2.3 
Where T = transmittance  
A logarithmic relationship exists between the transmittance (T), and concentration of 
compound (I) 





Since there is a direct relationship between absorbance and concentration, the concentration of 
a solute can therefore be determined using Equation 2.4. However, there are certain limitations 
with the law considering solutions can ionise at higher concentrations or solutes within a 
solution could precipitate to give turbid or cloudy suspensions that may alter absorbance, and 
consequently provide a wrong concentration profile. As such, it is important to note that the 
law is more accurate at low concentrations.  
A combination of very little sample preparation and how it can be easily coupled with a flow-
through system, makes it a suitable technique for the determination of model compound 
concentration in this research. However, considering different chemical modifications 
employed in modifying PDMS membrane, it was necessary to support the technique with high-
performance liquid chromatography (HPLC), as discussed in Section 2.3.1.8. 
2.3.1.5 Brunauer-Emmett-Teller Technique 
The Brunauer-Emmett-Teller (BET) technique is a physical method used to study surface 
properties of materials. The method uses condensation or adsorption of a process gas, (usually 
N2, Ar or CO2) with known sizes onto the surface of sample material analysed. The quantity of 
gas adsorbed on the sample material, and sample pressure obtained, are measured at a constant 
temperature corresponding to the boiling point of the process gas used in the analysis, and this 
data is used to produce an adsorption-desorption isotherm and subsequently, porosity 
calculations.  
This technique is used in this study to quantify changes that may occur as a result of 
modification processes as it relates to changes in permeation profile. Results obtained with the 
help of the technique, further helps to inform an opinion about the effect of modification on 
the membrane surface area, so that associated permeation changes can be attributed to chemical 





membrane surface and the model compounds, and not as a result of physical change from the 
membrane. 
The principles of BET rely on the ability of a monolayer gas formation on a given sample (the 
number of adsorbed molecules within the sample surface) and by fitting the experimental 
adsorption data into the BET equation, then the total surface area of given sample can be 
obtained. Hence, when a pre- and post-sample analysis are compared, resultant changes in 
surface area, can be easily identified. 












)    Equation 2.5 
In the BET equation depicted in Equation 2.5, P is the actual gas pressure, V = volume of gas 
absorbed by the material, Po = saturation pressure of a given temperature, Vm = monolayer 
capacity, and C is a constant (representing enthalpy of adsorption). Specific surface is obtained 
using this equation by simply multiplying monolayer capacity with cross-sectional area of the 
individual molecule absorbed. However, application of the principle is based under the 
assumption that: the surface is flat and all sites on the surface are equivalent; only a monolayer 
is formed i.e. no lateral interactions between adsorbed molecules; an infinite layer can be 
formed and molecular adsorption energy is equal to the liquefaction energy except for 
molecules in the first layer (Kruk & Jaroniec, 2001). 
In this study the process was carried out using a Micromeritics ASAP 2020 physisorption 
analyser (Figure 2.3).  Samples were degassed at 50 ℃ under vacuum for 18 hours using 
nitrogen as the process gas. This step in the process helps remove unwanted contaminants 
(gases and vapours) from the membrane surface which may interfere with the experimental 





surface area was determined using nitrogen vapour adsorption data (77 K) and were evaluated 
by the Brunauer-Emmett-Teller model. 
 
Figure 2. 3 A typical BET analyser (UoH Chemistry Lab, 2019) 
 
2.3.1.6 Attenuated Total Reflectance-Fourier Transform Infra-red spectroscopy 
Attenuated Total Reflectance-Fourier Transform Infra-red spectroscopy (ATR-FTIR) is 
another type of Fourier transform Infrared Spectroscopy (FTIR). FTIR, just like most 
spectroscopic techniques consists of a light source, monochromator and a detector. One of the 
main advantages of FTIR is its ability to analyse solid, liquid and gaseous substances with little 
or no sample preparation required.  
The infrared (IR) technique generally involves sources of radiation (light sources), which are 
usually inert solids that are heated electrically to initiate thermal emission of radiation in the 
infrared region of the electromagnetic spectrum, and these beams are subsequently directed 
towards a monochromator which selectively allows the light to interact with the sample, hence, 





of the sample. However, while the working principle of infrared spectroscopy remains the 
same, there have been changes in the analytical set-up over the years. 
The first type of IR was developed in the 1950s. Apart from the radiation source, it has an 
optical prism system made up of NaCl, which scans the sample material and produces spectrum 
results. IR produces light of different frequencies, but the monochromator installed in its 
system has a certain motor configuration which selectively opens as the emitted radiation 
reflects on it. As mirrors in the monochromator move, each wavelength of light within the 
emitted beam is periodically reflected at different modulated rates, such that each transmitted 
beam has a different spectrum. The resultant spectrum is captured by detectors, and this gives 
molecular information for the sample analysed. However, this type of IR has a narrow scan 
range and produces poor repeatability, which is why it is no longer in use today (Larsen, 2020).  
The second generation produced in the 1960s includes an optical chopper that has a double 
beam design. The incident radiation from the IR source is directed towards this optical chopper 
(that is equipped with special mirror gratings and slits), and it splits the incident radiation into 
two. The analytical design in this type of IR machine is such that one of the split beams travels 
towards a sample compartment and the other towards a reference cell, for analytical 
comparison. 
The incident beam that travels through the sample emits radiation, and the emitted radiation is 
directed towards a detector. The detectors are mostly classified as either quantum (photon) or 
thermal detectors. This additional optical splitter and monochromatic feature is the distinct 
feature compared to the first IR generation. There is a change between the incident beam 
travelling through the sample cell and the beam that travels through the reference cell, this 





gives the final spectrum. This type of IR is called dispersion IR (Larsen, 2020) as shown in 
Figure 2.4.  
 
Figure 2. 4 Schematic representation of a Dispersive IR. 
However, this type of IR has a low scan speed, low sensitivity and poor wavelength accuracy, 
giving rise to the third generation, i.e. ‘Fourier Transform infrared spectrometer’(FTIR).  
In FTIR, instead of juxtaposing data captured by detectors (emitted from a reference and 
sample cell), it requires a ‘Michelson interferometer’ which splits the IR radiation, allowing 
one path to run through the sample, and the other via a stationed mirror, and subsequently 
recombines the two emitted lights from both pathways. Consequently, measuring the change 
in intensity of these beams from different paths, with the help of an algorithm called the 
‘Fourier transform’, which transforms the acquired spectrum into wavenumbers in cm -1. This 
rendered the use of a reference beam obsolete (Perkins, 1986; Skoog, Holler, & Crouch, 2017). 
Consequently, broadening the application of IR spectroscopy.  
The infrared region is divided into the near-infrared region (12000 – 4000cm-1), mid-infrared 
region (4000 – 200 cm-1) and far-infrared region (50 – 1000 cm-1). However, in the case of this 





of most organic and inorganic compounds, hence the most commonly used, and the research 
interest is less concerned with the fingerprint region (> 400 cm-1) as quite distinct materials 
were used. 
However, the nature of the membrane analysed in this study necessitated the use of Attenuated 
total reflectance (ATR)-FTIR spectroscopy. This type of FTIR has an additional ATR crystal 
strategically placed in the sample compartment area. The sample material is in contact with 
this crystal, and reflection between IR incident radiation and the ATR crystal produces a change 
in refractive indices between the two materials, resulting in a phenomenon called ‘evanescent 
wave’, and this wave extends into the sample. The phenomenon allows consolidation of IR 
radiation and gives a more robust interaction with the sample, as shown in Figure 2.5. This 
additional boost and consolidation of the IR radiation into a confined area provides a higher 
limit of detection in samples analysed (Griffiths & De Haseth, 2007; Smith, 2011). 
                                                                           
Figure 2. 5 Schematic illustration of ATR single bounce cell 
In this study, comparative analysis specifically related to bond changes of modified and 
unmodified membranes was carried out using this technique. A Nicolet FTIR 380 machine was 
used, which was in attenuated total reflectance mode with a diamond crystal as the sensor. 
Omnic software was employed for data analysis and analysis wavelength was adjusted from 
400 – 4000 cm-1. Bonds corresponding to prominent functional groups were identified in 





of the sensor as shown in Figure 2.6, were addressed using other supporting techniques, such 
as optical microscopy. 
 
Figure 2. 6 Graphical and schematic representation of ATR-FTIR technique, illustrating 
working methods of the technique. (FTIR laboratory UoH, 2020) 
 
2.3.1.7 Permeation Analysis  
Permeation analysis using diffusion cells in a controlled hydrostatic and hydrodynamic donor 
and receptor compartment respectively, was experimentally performed in triplicate, for each 
model compound used. Each saturated solution of drug was prepared using pH 7.4 phosphate 
buffered saline. The buffer was prepared by dissolving 8.766 g of sodium chloride, 7.385 g of 
dipotassium phosphate and 1.034 g of dihydrogen potassium phosphate in 1 L of ultra-pure 
water (18.2 MΩ, Barnstead). pH adjustment was carried out using dilute concentrations of HCl 
and NaOH where necessary. 
Saturated drug solutions were prepared by adding an excess amount of sample drug in 10 mL 
sample vials containing buffer. Sample vials containing a micro-size magnetic stirrer were 





plate. This process is independent of the flow through measurement, as it is primarily aimed to 
acquire the saturated form of model drug intended for a given permeation analysis. 
Following the process highlighted above, resulting solutions were filtered, and added via a 
syringe, into the donor compartments of the flow through system to avoid bubbles. Openings 
on the donor compartment were occluded to maintain constant temperature and prevent 
evaporation. The donor compartment was mounted on a specialised solid support designed to 
have a hollow internal feature, where pre-heated water of approximately 35.5 ℃ circulated 
through, to help maintain a stable temperature within the donor compartment. Samples passing 
through specialised tubes that connected the donor and receiver compartment were collected 
from the receptor arm at 30-minute intervals for 6 hours and analysed using UV-visible 
spectroscopy and HPLC. Diagrams to illustrate the analytical process are shown in Figures 2.7 
and 2.8. 
A standard calibration graph of each drug (R2 ≥ 0.9.) was used to calculate its resultant 
concentration after the experiment, covering the concentration range of the samples obtained 
in the permeation analysis.  
 








Figure 2. 8 Schematic representation of a diffusion cell used for permeation analysis 
 
2.3.1.8 High Performance Liquid Chromatography 
This is a relatively straightforward analytical technique which was also employed in this study. 
Its principle is simply based on the distribution of analyte (sample material), between a mobile 
phase (eluent) and a stationary phase (column). Depending on chemical structures of different 
entities that may be present in the analyte, movement of these entities are staggered while 
passing through a stationary phase (mainly due to differences in physicochemical properties 
such as polarities, and level of affinity to the stationary phase), conveyed by the mobile phase, 
in a specialised set-up present in a typical high-performance liquid chromatography (HPLC) 
system. These interactions between the stationary phase material and the eluents are distinct, 
and consequently determines the time needed for each entity to be eluted. In other words, 
different constituents of a sample are eluted at different times, and the time each component 
takes to pass through the column is termed as the ‘retention time’, and it serves as a fingerprint 





Upon analytes leaving the stationary phase of the HPLC, different types of detectors are used 
to qualify the eluents, and this different detector type forms the main basis upon which HPLC 
systems can be classified.  
A typical HPLC set-up involves a solvent reservoir (mobile phase), a pump (which delivers the 
solvent at a high pressure and constant speed, to minimise noise), an injector valve (through 
which analytes are introduced to the system), a column (stationary phase), a detector (which 
produces a signal proportional to the amount of analyte emerging from the column, thus 
providing an avenue for quantitative analysis) and a data processing system. 
In this study, a Shimadzu HPLC system, equipped with a pump, oven, an autosampler and a 
UV-visible detector was used. A stainless steel C18 column, and an aqueous solution of 
acetonitrile [80:20] as the mobile phase solution was also used. 
The chromatographic conditions were established and are listed in Table 2.4. 









 5 µL C18 column 




Analysis software Lab solutions (LC-solutions), Shimadzu 
Eluent A (non -aqueous 
solution) 
Acetonitrile 
Eluent B (aqueous solution) Water 
Flow rate (mobile phase) 1 mL/min 
Injection volume 10 µL 
Method of Elution Isocratic (Constant flow of mobile phase solution) 
Column Temperature 30ºC 
Column operational method Reverse phase chromatography column 
 
2.3.1.9 Optical Microscopy 
The need to observe in detail changes that may have occurred on the surface of sample material 





Although the limiting magnifying power of optical microscopy is very much established 
compared to electron microscopy (X. Chen, Zheng, & Liu, 2011), the need to view a 
moderately enlarged form of the membrane sufficient enough to determine how grafted 
materials are physically attached and distributed on the material surface cannot be over-
emphasised. 
Although different types of imaging systems have been developed over the years, their basic 
concept remains the same. An optical imaging system requires objective lenses and an 
eyepiece. These objectives lenses simply magnify objects for the observer. When a sample 
material is placed in the space provided within the microscope, optical waves within the visible 
spectrum help generate an image of the sample, which is first cast on a focal plane. This image 
is magnified by an intermediate lens, which then reflects it on the eyepiece. The eyepiece also 
works as a magnifier, and subsequently a magnified and virtual image is provided for the 
observer. Spatial resolutions of any well-designed microscope are provided by the objective 
lens, and although the eye piece can serve as a magnifier itself, it cannot in principle help in 
increasing focus or improving resolution.  
Resolutions in optical microscopy can be determined using the Rayleigh equation (Mertz, 
2019; Tsujita, 1967) 
     ∆𝑟𝑜 = 0.62𝜆/n sin 𝛼    Equation 2.6 
Where ∆𝑟𝑜= minimum resolvable distance, 𝜆 = wavelength of the light source, n = refractive 
index between the lens and the object, and  𝛼 = half angle aperture – half inclination of the lens 
to the objective points.  
Optical microscopy can be divided into various types, including transmission and reflection 
(X. Chen et al., 2011). Transmission microscopy uses light that directly passes through a 





strategically installed inside the microscope, which illuminates non-transparent objects, and 
the reflected light is collected by the sample. The technique can also be classified based on 
observation methods such as, polarised light microscopy, dark field microscopy, and bright 
field microscopy. Although, bright field microscopy is sometimes employed, its dependence 
on an environmental light source and the fact that colourless materials are not visible using this 
technique, makes its use limited (Tatosian, Shuler, & Kim, 2005) 
In this study optical microscopy analysis was carried out using a Keyence digital microscope 
VHX-2000 equipped with VH-z250R sensor, set at a multi-scan mode. Samples were placed 
in a sterilised glass plate to maintain a flat surface which enabled autofocus on the machine. 
The stage was also adjusted to a 20 mm working distance and x 250 magnification was 
maintained throughout the process. The machine was set to reflectance mode.  
2.4 Conclusion 
In summary, this chapter provides a list of materials and analytical methods utilised in this 
work, including justification for all the processes employed in this study. Using the techniques 
discussed, results and discussion arising from these experiments are subsequently presented in 
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It is known that the surface of PDMS membrane is non-porous, similar to human skin, and 
xenobiotics can only permeate through the membrane with the help of physicochemical 
interactions by atoms or molecules present on the surface of the membrane (as discussed in 
Chapter 1). However, the exact mechanism through which substances permeate membrane 
needs to be established and understood before any attempts to modify it can be undertaken.  
In this study, to effectively compare any membrane to that of skin, an approach was undertaken 
of comparing permeation data through PDMS membrane with that of skin, i.e. by trying to 
mimic experimental conditions similar to the skin surface. 
3.2. Results and Discussion 
3.2.1. Standard PDMS membrane 
3.2.1.1 Permeability Studies 
Generally, two distinct approaches are employed in drug permeation analysis namely, a finite 
and infinite dose approach. The basic difference between the two approaches is such that the 
former requires a known and calculated drug concentration that can be changed and varied 
according to suitability of the intended experiment(s), while the latter employs a constant 
concentration usually from the saturated form of the drug in question (Neupane, Boddu, 
Renukuntla, Babu, & Tiwari, 2020). The infinite dose approach was adopted in this study, and 
this is simply to eliminate variations that may result from different drug concentrations and 
preparations in the analysis. In other words, variables were meant to remain as low as possible, 
making it easier to track and attribute changes resulting from surface membrane modifications. 
Hence, super saturated solutions (infinite doses) were prepared for all model compounds in this 





Standard permeation methodology was adopted (according to European Medicines Agency 
(EMA) Guidelines) for in vitro permeation studies with slight modifications: the system was 
allowed to equilibrate for 24 hours prior to analysis, the flow rate was adjusted to 100 rpm and 
the total experimental duration was 6 hours to cover the therapeutic window. These 
modifications were all adopted to more closely replicate the human system, for example 
equilibration was necessary to allow the donor compartment to attain 36 ℃. Table 3.1 
highlights the mean cumulative mass of drug compounds used in this chapter, and in an attempt 
to relate these values with solubility as it relates to permeation studies, the drugs 

















Table 3. 1 Cumulative mass of model drugs used in this chapter alongside their 
biopharmaceutical classification, which are: caffeine (CAF), lidocaine (LID), benzoic acid 
(BZA), ethyl paraben (EPB), benzocaine (BEN), salicylic acid (SAL), ibuprofen (IBU), 
diclofenac (DCF), ketoprofen (KPF), antipyrine (ANT), tetracaine (TTC), procaine 
hydrochloride (PRC), and pentoxifylline (PTX) permeated through standard PDMS membrane 
following permeation analysis (mean ± standard deviation, rounded to whole numbers, n = 3). 
 
Compounds Mean cumulative mass 
permeated after 6 hours 
(μg/cm2) 
BCS* 
CAF 72 ± 4 I** 
LID 3351 ± 23 II** 
BZA 4513 ± 18 III** 
EPB 323 ± 09 
** 
BEN 2294 ± 16 II** 
SAL 862 ± 06 I** 
IBU 1176 ± 11 II** 
DCF 134 ± 04 II** 
KPF 85 ± 04 II** 
ANT 313 ± 02 I** 
TTC 1551 ± 11 II** 
PRC 33 ± 01 
** 











The concentration of model pharmaceutical compounds was calculated using equations 
obtained in their standard calibration plots (R2 = 0.99) (Figure 3.1 and 3.2). These 
concentrations were subsequently integrated to give cumulative mass. However, the flow 
through system cells used in this work have a diffusion surface area < 1 (0.56 cm2), for 
uniformity, all cumulative mass obtained herein, were adjusted to reflect cumulative mass/cm2 
for effective comparisons. 
 
Figure 3. 1 Caffeine calibration at 272 nm 
 
Figure 3. 2 Salicylic acid calibration at 234 nm 
Interestingly following the permeation process, acceptable steady state was obtained (Figure 
3.3 – 3.5), as all experiments undertaken with model compounds had regression values of R2 
≥ 0.9. At this stage of the research, it was possible to draw the following conclusions 
regarding the use of standard PDMS (N-PDMS) membrane for permeation analysis. 





✓ The permeation profiles of compounds analysed are within an acceptable limit 
that can be modified to mimic permeation profiles through skin 
✓ It is a selective permeable membrane, as each compound used gave a distinct 
permeation profile, as a result, a quantity-structure activity can be established, 
which will help in predicting its behaviour. In other words, selectivity, activity 
and stability were established. 
✓ Steady state (Jss) was obtained, and thus allowed application of Fick’s law and 
the introduction of a physical factor (permeation coefficient Kp), which will 
allow a comparison to be made between experimental data, and that of human 
skin. 
 






Figure 3. 4 Steady state flux of caffeine through standard PDMS 
 
 
Figure 3. 5 Steady state flux of diclofenac through standard PDMS 
3.2.2. Optimisation Processes 
As stated in Chapter 1, the surface of PDMS membrane is made up of methyl groups, and to 
activate the surface atoms, a solventless process was adopted. The membrane was exposed to 
a series of plasma treatments to enable activation of its surface, before any further 
modifications were adopted. In this section of the work, these processes will be highlighted, 





3.2.2.1 Atmospheric Pressure Nonthermal Air Plasma Treatment of 
Poly(dimethysiloxane) 
Fundamentally, PDMS has a silicone-oxygen backbone, with a bond energy in the range of 
350-470 kJ mol-1. This high bond energy makes it stable thermally, with degradation occurring 
at about 350 o C (De Jaeger et al., 2008). The surface of the membrane is also embedded with 
methyl groups, making it relatively inert, consequently, making it challenging to chemically 
modify. It was seen in previous permeation analysis that compounds selectively pass through 
the membrane in relatively low amounts courtesy of the silicone-oxygen arrangements, and 
surface methyl groups. To modify this membrane therefore, it was necessary to create reactive 
sites, i.e. activate the membrane surface, to facilitate further modification. 
PDMS used in this study was treated under plasma; energy from the plasma facilitates 
abstraction of hydrogen from methyl groups present on the membrane surface, thereby leaving 
an unstable methylene group (-CH2). The hydrogen removed further reacts with air in the 
plasma chamber, or atmospheric oxygen to form a hydroxyl group (-OH). The hydroxyl group 
formed, attacks, and displaces the unstable methylene group that was left on the membrane 
surface. Consequently, a hydrolysed surface can be achieved because of the plasma treatment. 
Practically, the hydrolysed surface is suitable for further treatment, such as in the work of 
(Bodas, Khan-Malek, & Chemical, 2007), (Zhou, Ellis, & Voelcker, 2010), (Goda, Konno, 
Takai, Moro, & Ishihara, 2006) and (Waters, Finch, Bhuiyan, Hemming, & Mitchell, 2017). 
Although, there are other surface-activating methods, such as UV/irradiation (Schnyder et al., 
2003), which employ the same mechanism in hydrolysing the PDMS surface, the solventless 









Figure 3. 6 Schematic representation of the plasma treatment mechanism employed in this 
study to modify the surface of PDMS membrane. 
 
3.2.2.2 Scanning Electron Microscopy 
Amongst the spectroscopic techniques employed in this study to visualise surface changes on 
the membrane is Scanning Electron Microscopy (SEM). Upon plasma treating the membrane, 























This image represents the standard PDMS 
membrane surface (1-2 microns’ depth). It 
visualises the surface of the membrane prior 
to any form of modification. 
 
Similar to the description given by (Majeed 
et al., 2012), the membrane  shows a 
smooth and homogeneous surface.  
 
It is noteworthy to mention that the 
membrane was coated before carrying out 
the SEM analysis (Section 2.3.1.2). 
Additionally, the membrane was in 10 kV 
(accelerating voltage), and a working image 
distance of 15 mm. 
Permeation results presented in Section 
3.2.1.1 were carried out using this form of 
the membrane.   
 
























The image represents a plasma treated 
PDMS membrane surface (1-2 microns’ 
depth). Comparing this image to Figure 
3.7, one can easily see a striking 
difference between the two images.  
 
This change can be easily presumed to 
arise from possible deformity following a 
thermal process although this is not the 
case as it could not have been from a 
thermal process. In this result it is believed 
that a chemical interaction has likely 
occurred from the plasma process, given 
rise to the striking difference between the 
two images (Figure 3.7 and 3.8). 
 
The plasma parameters in this 
modification are air as the process gas, at 
100 W, flow rate of 8 SCCM and a 
treatment time of 120 seconds. 
 
NB. SEM parameters were kept constant 
throughout the study, for effective 
comparisons 
 
Figure 3. 8 SEM image of plasma treated PDMS (over cured) (× 500) 
 
Although, the above process seemed potentially successful from the SEM image, it presented 
a limitation in the overall aim of this study. Following the plasma treatment process, the 
membrane was used for permeation measurements, which resulted in over-absorption (results 
not shown). It became a disadvantage to this study especially how the plasma treated membrane 
was unable to maintain a concurrent permeation profile necessary for concordance after 
repeated runs (n =3). It was concluded that the membrane must have been subjected to an 
excessive exposure time, as a result Si-Ox membrane bonds became compromised, resulting in 
possible crack formation or structural damage, that may have led to the undesirable increase in 















 An optimised plasma treated PDMS 
membrane surface (1-2 microns’ depth).  
 
The plasma parameters used in the 
modification reported here remained 
similar to parameters presented in Figure 
3.8. except for the treatment time, that was 
reduced from 120 seconds to 90 seconds. 
 
The image presented shows a change, 
sufficient enough to suggest a response to 
the plasma treatment without necessarily 
compromising the membranes physical 
structure. 
 
The wrinkly-like effect seen in this study 
has also been similarly reported 
(Kaczorowski, Szymanski, Batory, & 
Niedzielski, 2015). 
 
Figure 3. 9 SEM image of plasma treated PDMS (optimised) (× 500) 
Following the process described in Figure 3.9, the membrane was also subjected to permeation 
analysis, in order to evaluate the effect of plasma treatment in relation to its permeation profile. 
Results of this analysis are presented in Table 3.2 and Figure 3.10 that shows graphical 
representation of the permeation profiles.  
The wrinkling effect observed following plasma treatment has been previously reported and 
attributed to an effect arisen from possibly oxidation of a silicon surface, which can result in 
elasticity contrast and increased mechanical strain between the surface of the material and its 
remaining bulk (Cordeiro, Zschoche, Janke, Nitschke, & Werner, 2009; Lee, Hong, Park, Lee, 






Table 3. 2Cumulative mass of caffeine (CAF), lidocaine (LID), ethyl paraben (EPB), 
benzocaine (BEN), salicylic acid (SAL), ibuprofen (IBU), diclofenac (DCF), and ketoprofen 
(KPF) permeated through standard PDMS membrane and plasma treated PDMS membrane 
following permeation analysis (mean ± standard deviation, rounded to whole numbers, n = 3), 
presented for comparison. 
 
Compounds Membrane type Mean cumulative mass 
permeated after 6 hours 
(μg/cm2) 
BCS 
CAF Normal PDMS  72 ± 4 I 
 Plasma treated 
PDMS 
74 ± 6  
LID Normal PDMS  3351 ± 23 II 
 Plasma treated 
PDMS 
3362 ± 31  
EPB Normal PDMS  323 ± 09 II 
 Plasma treated 
PDMS 
327 ± 04 
 
SAL Normal PDMS  862 ± 06 I 
 Plasma treated 
PDMS 
890 ± 11  
IBU Normal PDMS  1176 ± 11 II 
 Plasma treated 
PDMS 
1076 ± 07  
DCF Normal PDMS  134 ± 04 II 
 Plasma treated 
PDMS 
134 ± 02  
 
BCS = Biopharmaceutical classification system 
Biopharmaceutical classification (BCS) refers to an experimental model that measures 
permeability of compounds in relation to their solubility. It is essential to consider and take 
cognisance of the BCS concept, as any physiochemical properties of drug that may influence 
rate of permeation needs to be established prior to modification. Hence, any change can be 
appropriately and effectively considered as resulting from the modification process, and to 





compounds independent of this study, the BCS can further help in establishing a model for 
these predictions, as drugs within the same BCS can be grouped and analysed. 
 
Figure 3. 10 Steady state flux of diclofenac through standard and plasma treated PDMS 
membrane. 
 
Permeation measurement using the optimised form of the plasma treated membrane shows a 
reduction effect when comparing its value with that of the normal membrane. What this process 
shows is that the parameters used in this plasma process produced energy sufficient enough to 
bring about changes observed using SEM, without compromising the nature of the membrane, 
meaning the much-needed selectivity and stability of the membrane remained intact. Hence the 
optimised version was more appropriate for further investigation.  
3.2.2.3 Water Contact Angle analysis 
Static contact angle measurements in this analysis served as a supporting technique to augment 
the findings visualised from SEM images following the plasma process carried out on the 








Figure 3. 11 SEM of normal (a), plasma treated (b) (over cured) and optimised (c), PDMS 
membranes (left), alongside their respective water contact angle measurements (right). 
 
Although it is presumed that the atomic entities between normal and plasma treated PDMS 
membrane differs on the surface, the bulk material remains the same, as such the membrane 
surfaces remained a flat and homogeneous surface, and by extension, Young’s postulates can 
be applied. Therefore, for wettability analysis, standard PDMS membrane showed static 
effective contact angles (SEC- angles) of 97.28° (± 1°). This shows that the membrane was 
hydrophobic (contact angle ≥ 90) (Ramirez-Canon, Miles, Cameron, & Mattia, 2013), and also 





However, following treatment of the membrane with plasma, SEC angles of the resultant 
membrane reduced from 93.28 ° to 7.09 ° (Figure 3.11). According to Young’s description this 
newly modified material can be considered a hydrophilic membrane. More crucial to this study 
is how these changes can be attributed to the earlier proposal that the new surface might contain 
hydroxyl groups (-OH) which can easily increase affinity with water molecules (-H2O) 
therefore, increasing hydrophilicity. This result emphasises the importance of altering the 
PDMS surface in order to achieve an increased propensity of a chemical interaction.  
It appears that the nano-ridged like structures in Figure 3.11b can be as a result of over-curing 
the membrane, and as such can lead to a compromise in the membrane integrity, therefore, 
parameters used in the treatment were optimised, SEC angles of the newly formed membrane 
(Figure 3.11c) were obtained with an average value of 15.58 °. 
Within this study it was possible to say with certainty that the modified membrane will be more 
reactive and susceptible for modification, as has been reported in other studies. It can conclude 
that the increased wettability on the PDMS membrane surface can lead to an increase in its 
reactivity (Karakoy, Gultepe, Pandey, Khashab, & Gracias, 2014). However, although the 
results were ideal, and in good agreement with literature, it was difficult to say with certainty 
that liquids dropped on the plasma treated membranes cannot be trapped in the ridge-like 
interstices. This could be an issue as it could lead to trapped air and hence form a solid-air-
liquid interface, resulting in a small degree of uncertainty with reported contact angles of 
treated membranes. 
3.2.2.4 Attenuated Total Reflectance-Fourier Transform Infra-red spectroscopy 
ATR-FTIR analysis was undertaken with results presented in Table 3.3. The technique was 
used to analyse standard membrane as well as plasma treated membrane for confirmation of 





effectively detect any change that might occur as a result of the modification process. Surface 
methyl groups were confirmed by symmetrical stretching vibrations at 2962.4 and 29632 cm-1 
for untreated and treated membranes respectively. Asymmetric deformations of methyl groups 
for treated membranes were also observed at 1411.9 cm-1. Symmetric deformation of methyl 
groups for untreated and treated membranes was at 1257.1 and 1257.8 cm-1 respectively.  Peaks 
from stretching vibrations at 1004.7, and 1005.7 cm-1 were attributed to Si-O-Si bonds, for 
untreated and treated membranes respectively. This analysis in a way serves as a quality control 
for PDMS membrane as results obtained were in close agreement with reported works by 
(Bodas & Khan-Malek, 2006; Kim & Jeong, 2011). 
O-SiCH3 were confirmed by peaks at 784.4 and 783.7 cm
-1, the presence of C-SiCH3 groups 
were confirmed by 669.8 and 669.8 cm-1 for untreated and treated membranes respectively. 
There was an expectation that the technique might detect the newly proposed hydroxyl group 
(-OH) on the plasma treated membrane. However, the plasma process was a surface treatment, 
hence chemical changes were limited to membrane surface, consequently, penetration depth of 

















Normal PDMS Plasma treated PDMS 
νs (CH3) 2962.4 2962.0 
δas (CH3) 1411 1411.9 
δs (CH3) 1257.1 1257.8 
Si-O-Si 1004.7 1005.7 
Si-O 481 477 
O-SiCH3 784.6 783.7 
C-SiCH3 669.8 669.8 
C – OH N/A N/A 
 
3.2.3. Glycerol Attachments on Plasma treated Poly(dimethylsiloxane) membrane 
3.2.3.1. Introduction 
Glycerol (1,2,3- propanetriol) is a colourless, odourless and viscous liquid (Pagliaro & Rossi, 
2008), and it is one of the most versatile chemical substances known to man (Lourhraz & El 
Asli, 2018). It has a melting point of 18.2 ℃ and a boiling point of 290 ℃, it is completely 
soluble in water and alcohols, slightly soluble in many common solvents such as ether and 
dioxane, and insoluble in hydrocarbons. Combination of its high flexibility, possibility of 
intramolecular hydrogen bonds formation and intermolecular solvation all due to its hydroxyl 
groups, makes it suitable for the intended process. 
The idea of attaching glycerol to the plasma treated membrane surface was partly coined from 
behaviour of the plasma treated membrane when it was subjected to permeation analysis as 
reported in Table 3.2. In that analysis, a slight change in permeation profile of this treated 





treated membrane was able to maintain its initial selectivity throughout the process. It was then 
proposed that an additional layer made up of primarily hydroxyl groups (similar to plasma 
treated surface) could form a basis for a more detailed insight on how the membrane surface 
worked. This would not only solidify the earlier proposal about the nature of the membrane 
surface but will also allow the formation of an additional layer (as proposed in Figure 3.6). 
Such a membrane could lead to a decrease in permeation by simply filling possible voids 
created by the plasma treatment, and forming a more tightly packed membrane, helping to 
achieve the aim of this study. 
It is a known fact that attachment of materials on inorganic polymer surfaces remains a 
challenging task (Gill & Ballesteros, 1998), despite the considerable research that has been 
focused on the field. This study involves applying a technique that was first introduced in 1973 
by Horning’s group, known as atmospheric pressure ionisation (API), later renamed 
atmospheric pressure chemical ionisation (APCI) (Horning, Horning, Carroll, Dzidic, & 
Stillwell, 1973). The technique works by introducing a sample solution via a sample injection 
port which interacts with a high-pressured stream of pre-heated carrier gas (usually nitrogen), 
released from a separate gas inlet valve, resulting in the formation of micro-droplets of the 
sample. Subsequently, ionisation of this micro-droplet can occur when in contact with high 
voltage discharge (corona discharge) (Dass, 2007). The principle of this technique can be 
exemplified by the working system of an electronic cigarette (e-cig) (Liu, 2015), that comprises 
of an atomiser, which is a chamber comprising of specialised coils that are powered by a battery 
source and can provide the needed voltage to heat and drive the atomisation of sample solutions 
present in e-cigarettes.  
This methodology was extended to fuctionalised siloxane in this study. The advantage was 





increase in ionisation efficiency caused by the high pressure used in the method, leading to 
more gas phase collisions, a principle that has been previously reported (Watson & Sparkman, 
2007), in other words, adopting the chemical vapour deposit methodology. 
3.2.3.2. Glycerol coat method 
Glycerol (10 mL) was introduced into a reactor which was equipped with a coil, heated by a 
battery source, all enclosed in a compartment considered as the atomisation unit. The reactor 
contained a 3.7-volt battery capacity and 2.4Ω atomiser, capable of producing about 5.5 watts 
of power. This power was strong enough to vaporise the glycerol.  
Freshly plasma treated PDMS of square sizes sufficient to cover the effective area of diffusion 
cells used in permeation analysis (≈ 0.56 cm-2) were used in the process. The membranes were 
placed at a close distance to the exit point of the glycerol. The process lasted for 3 hours and at 
this stage a comparative measurement of the residual glycerol indicated 3 mLs was used in the 
process. The temperature of the reactor was kept at about 50 ℃ to support the condensation 
reaction. After the modification process, in trying to address an unwanted leaching effect 
attributed to the PDMS membrane (Bodas & Khan-Malek, 2007) and creating a more 
homogeneous surface, the coated membrane surface was exposed to a nitrogen atmosphere for 
10 minutes this can also help in preserving the membrane from unwanted interaction with 
atmospheric air. A diagram to illustrate this process is shown in Figure 3.12 and the associated 








Figure 3. 12 Schematic representation of chemical vapour deposit procedure - technique 






Figure 3.13 Proposed reaction process of chemical vapour deposit of glycerol on plasma 
treated PDMS membrane. 
 
The chemical vapour deposit method is a tool in improving dispersion of various sample 
materials on surfaces or inner matrices of polymer materials, thereby improving some of their 





Volcke et al., 2010; Zhang et al., 2018). The process can be grouped mechanistically into two 
categories (Majeed et al., 2012) viz-a-viz: (a) binding of functional groups on a π-conjugated 
skeleton via covalent attachment or (b) physical adsorption from a variety of functional 
molecular interactions via a non-covalent bond (Hwang et al., 2011). The overall mechanism 
for silane bond formation depicted in Figure 3.13, has been reviewed in detail by (Pape & 
Plueddemann, 1991; Plueddemann; Tesoro & Wu, 1991). Alkoxysilanes undergo hydrolysis 
by both acid- and base-catalysed mechanisms, and in contrast with chlorosilanes and 
acetoxysilanes, products from alkoxysilane hydrolysis do not propagate hydrolysis reactions. 
In other words, these products are stable when in contact with water. The same factors which 
influence hydrolysis of alkoxysilanes also influence condensation of silanols with other 
silanols or alkoxy precursors (Arkles, Steinmetz, Zazyczny, Mehta, & Technology, 1992). In 
other words, the proposed modified membrane can be stable enough to undergo permeation 
analysis and is therefore a potential advantageous modification of PDMS. 
 
3.2.3.3 Scanning Electron Microscopy of modified PDMS membrane 
Following the modification process presented in Section 3.2.3.2, modified membrane was 
analysed using SEM analysis with the results displayed in Figure 3.14. The experimental 










Figure 3. 14 SEM of standard (a), plasma treated (over cured and optimised (b) and (c) 
respectively) and modified (d) PDMS membranes. 
 
In Figure. 3.14 (d) above, a notable change in the membrane surface can be visualised, 





easily be attributed to the modified membrane from the SEM image. A presumed crack can 
also be seen from the image, which may be possible from the nature of the deposited glycerol. 
However, structural integrity of the membrane was not compromised as the process was a mild 
technique and was more technically ascertained using permeation analysis. The presumed 
crack was attributed to a discontinuous layer resulting from the glycerol coat. Spots seen on 
the membrane surface were possibly also because of coalescing small particles that were 
deposited on the membrane following the process. 
 
3.2.3.4 Water Contact Angle analysis 
WCA analysis was undertaken, and results presented in Figure 3.15, alongside different 






Figure 3. 15 SEM of standard (a), plasma treated (b) (over cured) and optimised (c) and 
modified (d) PDMS membranes (left), alongside their respective water contact angle 
measurements (right) (× 500). 
 
Due to a similar proposed hydroxyl group on the surface of the membranes (plasma treated 
membrane and membrane coated with glycerol Figure 3.15), a decrease in WCA was primarily 
envisaged. Moreover, the water-soluble nature of the coated material (glycerol) was another 
reason why it was assumed that contact angle would decrease following the modification 





plasma treated membrane i.e. from 15.58 ° to 29.24 °. However, it is important to note that an 
additional layer resulting from the coat was achieved, which explains its smoother surface, and 
possibly, the increase in contact angle. In other words, a correlation between surface 
smoothness and hydrophobicity takes precedence, and this is also in line with previous work 
by (Majeed et al., 2012).  
 
3.2.3.5 Permeation Analysis 
Permeation analysis using diffusion cells (as described earlier) was performed using seven 
pharmaceutical compounds namely, caffeine, diclofenac, ibuprofen, benzoic acid, ethyl 
paraben, butyl paraben and salicylic acid. Each saturated solution of drug was prepared using 
pH 7.4 phosphate buffered saline. The buffer was prepared by dissolving 8.766 g of sodium 
chloride, 7.385 g of dipotassium phosphate and 1.034 g of dihydrogen potassium phosphate in 
1 L of ultra-pure water (18.2 MΩ, Barnstead). pH adjustment was carried out using dilute 
concentrations of HCl and NaOH as necessary. 
Saturated drug solutions were prepared by adding an excess amount of drug in 10 mL sample 
vials containing buffer. The sample vial containing a micro size magnetic stirrer was mounted 
in a water bath maintained at ~32 oC for 24 hours, equipped with a magnetic stirrer plate. The 
resulting solution was filtered, and added via a syringe, in the donor compartment to avoid 
bubbles. Openings were occluded to maintain constant temperature and prevent evaporation. 
Samples were collected from the receptor arm at 30-minute intervals for 6 hours and analysed 
using UV-vis spectroscopy. 
A standard calibration graph of each drug (R2 ≥ 0.9.) was used to calculate its resultant 
concentration after the experiment, covering the concentration range of the samples obtained 
in the permeation analysis. It bears mentioning that freshly prepared serial drug concentrations 





using the same graph for all analysis involving a particular drug. This is in line with standard 
operating procedures as contained in the Accreditation of laboratory competence (ISO/IEC 
17025). However, the Act allows usage of a concentration standard (1000 ppm in the case of 
this study, unless defined otherwise) more than once, from which a series of calibration 
standards should be prepared daily and valid for only one batch run.  In line with that, the 
concentration standard for stable drugs (such as caffeine) were stored under a controlled 
environment and sometimes used more than once. 





Table 3. 4 Cumulative mass of caffeine (CAF), and salicylic acid (SAL), permeated through normal, plasma treated and modified PDMS 
membrane alongside their Permeation coefficient (Kp) values, compared with literature values, following permeation analysis (mean ± standard 






Cumulative mass (µg/cm2) Permeation coefficient (Kp) values  

































An infinite dose approach was employed in this permeation analysis. This approach was 
adopted to ensure an accurate comparison could be made between experimental and in-vivo 
permeation coefficient (Kp) values obtained from literature using human tissue. Baba et al 
reported this approach as a vital measure for evaluating permeation of in vitro models (Baba, 
Takahara, & Mamitsuka, 2015). 
Two different compounds were presented herein, partly because they cover a distinct range of 
therapeutic classes i.e. keratolytic agents, and central nervous system stimulants, and because 
they presented interesting results compared with the previous membrane permeation data.  
Kp values of the compounds (Table 3.7) indicates significant differences between standard and 
modified membranes. Values regarding drugs interacting with the membrane prior to 
modification were necessary as they would be essential to compare any change that might occur 
when analysing drug permeation through treated membrane.  
Results obtained from salicylic acid indicated a 9.6 % increase in Kp value after treatment. 
Although, the supposed increase in hydrophilic groups on the surface of the treated membrane 
can serve as a rate limiting step for drugs (Bhuiyan & Waters, 2017), thus resulting in low 
permeation, the relatively high log P value (2.06) (Chemspider) of salicylic acid meant that the 
drug is lipophilic in nature, hence is less affected by an increase in hydrophilicity of the 
membrane. Moreover, contact angle measurements indicated an increase in contact area of the 
treated membrane hence, resulting in more affinity of drug to the membrane, which can also 
serve as a potential factor for an increased permeation value.  
However, in the case of caffeine, Kp values remained similar for the treated vs. untreated, 
although, with a slight increase in cumulative mass of compounds permeated through modified 
membrane. This observed increase might be because of the hydrophilic nature of caffeine (log 





3.2.3.6 Sequential silanisation alongside PDMS-PEG BCP Co-Polymerisation 
PDMS silicon membrane, 0.3 mm thickness with approximately 0.6 cm
2 
size was utilised in 
this process. The membrane was plasma-treated then cured with 1 mL dimethylphenylsilanol. 
The process was a wet process, and the reaction was carried out in an ethanolic medium (~ 5 
mL). PDMS-PEG BCP curing agent was also added to the reactor (~ 1 mL). The entire reaction 
process lasted for 2 hours. 
Subsequently, the membrane formed was placed on an aluminium foil covered glass plate and 
introduced in an oven adjusted to 50 ℃ for 24 hours to completely cure and evaporate any 
excessive solution from the product and to further drive the process.  
 
3.3. Conclusion 
It is widely accepted that the surface of human skin comprises of tightly packed materials that 
only allow substances to selectively permeate through them via physicochemical interactions. 
It is based on this understanding that it becomes necessary to try and understand the working 
principle of PDMS, in order to effectively provide it as an alternative to human skin. This 
membrane has already shown promising indicators to replace skin from its very low 
permeability and selectivity. Moreover, the membrane has limited ethical criticism, legal 
constraints and has heightened availability which are all added advantages. However, it still 
shows an over-estimation of permeation when compared with human skin.  
In this chapter PDMS membrane was studied in detail and attempts were made to modify it. 
The inert nature of the membrane surface was overcome following atmospheric pressure 
nonthermal air plasma treatment and in line with reported literature, methyl groups present on 
the membrane surface were considered to be replaced with hydroxyl groups. Two analytical 
techniques, namely scanning electron microscopy (SEM) and static water contact angle (WCA) 
measurements were used to confirm this modification. Following plasma treatment, the 
resultant membrane was subjected to permeation analysis with a clear difference between 





to further saturate the surface of the membrane with similar functional groups achieved via 
plasma treatment i.e., hydroxyl groups. It was proposed that an additional layer comprising of 
the same group can reduce permeation of the membrane and at the same time maintain its 
already established selectivity. 
A selection of model drugs indicated a considerable difference between plasma treated 
membrane and the modified membrane, indicating a successful modification process. 
However, it was clear that a heterogeneous surface is needed to effectively mimic the skin 
surface, being the skin a heterogeneous layer itself, rather than having a surface comprising 
mainly of hydroxyl groups, rendering it a homogenous layer. 
Optimised parameters in surface treatment of the membrane achieved in this chapter, which 
increased the membrane chemical reactivity and compatibility, introduced a plethora of 
opportunities for a more robust modification process, some of which are presented in Chapters 
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Chapter 4  





















In the previous chapter it was demonstrated that PDMS could be modified to contain hydroxyl 
groups instead of methyl groups on its surface, and this modification renders it more reactive 
chemically. Following that process, glycerol material was attached on the plasma treated 
membrane surface following a condensation process, in an attempt to further treat the 
membrane. It was concluded that a more robust surface, preferably comprising of 
heterogeneous entities could possibly bring about a more desired outcome, in terms of a skin 
mimic system. 
The aim of this chapter is to identify and study different functionality that is compatible with 
plasma treated PDMS membrane, capable of driving effects strong enough to result in 
permeation profile changes. More specifically, chemical group functionalities well-suited with 
plasma treated PDMS membrane were considered, namely: alkyl, phenyl, embedded polar 
groups, pentafloro phenyl, alkylcyano derivatives and other groups were incorporated on the 
polymer surfaces, with the aim of altering surface properties of the membrane.  
These compounds were selected on the basis of their physicochemical properties which makes 
them distinct and suitable for this purpose. For example, alkyl derivatives are known to separate 
analytes base on their degree of hydrophobicity and log P values, phenyl derivatives based on 
π-π bond interactions and embedded polar groups due to their unique binding property as a 
result of heightened affinity and selectivity with surface silanol groups. This is the reason these 








4.2. Sequential Silanisation using Dimethylphenylsilanol. 
4.2.1. Background 
Dimethyphenylsilanol (DMPS) is an alkoxysilane, primarily selected to impart its reported 
lipophilic properties to the already established hydrophilic PDMS surface, such that a Si-O-Si 
bond attachment is achieved between the polymer substrate and the DMPS reagent, via a 
silanisation process. Organosilicon compounds, such as DMPS utilised in this study, have been 
previously reported to impart lipophilic properties on hydrophilic aliphatic silanes, and these 
modified forms are then adopted for chromatographic purposes (Virtanen, Kinnunen, & Kulo, 
1988). 
The surface modification process represents an important tool for the preparation of a large 
variety of differently functionalised solid inorganic polymer membranes, incorporating a 
variety of functional groups. Specifically, in this study, several criteria, such as the high yields 
obtained under mild reaction conditions, compatibility of different functional groups, no 
required catalytic activation and the absence of by-products (Lummerstorfer & Hoffmann, 
2004), are all advantageous for the intended process. 
Essentially, the silanisation process, i.e. coating hydrolysed surfaces with an organofunctional 
alkoxysilane molecule thereby forming a Si-O-Si bond via covalent attachment, was 
investigated in this study. The aim was to achieve an alkoxysilane functionalised PDMS 
membrane. 
It is also paramount to mention that alkoxysilanes have been widely accepted to constitute a 
stable membrane, mostly attributed to the presence of the Si-O-Si bond (Arkles, Steinmetz, 
Zazyczny, Mehta, & Technology, 1992). This desired stability forms part of the reason this 





4.2.2. Silanisation method  
In this study, the approach reported by (Sui et al., 2006) was adopted, i.e. hydroxyl groups 
present from both reactants (DMPS and plasma treated membrane) were reactable, 
consequently, a condensation reaction could occur which may lead to attachment of the silane 
reagent on the membrane surface, thereby, creating a Si-O-Si bond.  
 
Figure 4. 1 Proposed reaction scheme (A) Un-modified membrane (B) Plasma-treated 
membrane (C) Modified membrane.  
 
The general mechanism depicted in Figure 4.1 for silane bond formation was carried out in an 
acid-catalysed medium. Ethanol was used as solvent in the process to enhance an even 
distribution of the silane reagent, thereby reducing the likelihood of steric hinderance. To 
maintain an acidic environment (which can improve the condensation process) the measured 
pH (~ 8) was lowered by adding 1-2 drops of dilute hydrochloric acid thereby adjusting it to 
approximately pH 5.5. Approximately 1 mL of the silanising reagent (DMPS) was introduced 
into the reactor already containing 5 mL ethanol, using a glass pipette. This stage of the reaction 
lasted for 30 minutes and the temperature was maintained at 40 ℃.  
Although the reaction was a wet process (solution based), it was primarily aimed to achieve 





reaction, membranes from the reactor were collected, placed on aluminium foil and conditioned 
in a vacuum desiccator to promote formation of a silane monolayer. This process lasted for 15 
minutes. Subsequently, membranes were placed on a glass plate covered with aluminium foil 
and introduced into an oven at 120 ℃ for 15 minutes to completely cure and evaporate any 
excessive solution from the product and to further drive the process.  
The resultant membrane was dried under a nitrogen atmosphere, in line with the reported 
process (Ou, Hu, Xue, Wang, & Li, 2013), which was an additional step to ensure physical 
dryness i.e. removal of solvent, complete condensation and to create a relatively stable surface. 
All parameters used in this process such as water content, solvent utilised, age of solution, time 
required in each stage of the reaction, applied temperature to mention but a few were carefully 
ascertained prior to commencing the reaction and in some instances optimised. This was 
necessary as integrity of the membrane needs to be intact in order to achieve the overall aim of 
this research.  
Recovery also is an important aspect of any chemical reaction, for environmental reasons and 
to reduce cost as well. In addition, there was concern as to whether the silane may choose to 
react with the solvent used (ethanol) instead of the PDMS membrane. Fractional distillation 
was employed in this regard because of the close boiling points that exist between DMPS and 
ethanol (62 ℃ and 78 ℃ respectively) (Pubchem). Two separated fractions obtained were 
further analysed using FTIR, the resultant peaks obtained from the separate fractions were cross 
matched with their initial spectra (prior to the reaction) and were found to be similar. This 






4.2.3. Scanning Electron Microscopy of modified DMPS-PDMS membrane 
It should be noted that changes such as the one depicted in Section 4.2.2. ought to be strong 
enough to bring about visible differences between modified and un-modified membranes. It 
was in line with this understanding that proposed DMPS-PDMS membrane was first and 
foremost observed using SEM. However, to critically appraise the entire modification process, 
SEM analysis was carried out in a stepwise manner. Firstly, prior to conditioning of modified 
membrane under nitrogen, SEM data was acquired then again following the silanisation process 
and curing of the membrane, and finally at the end of the process a separate SEM image was 
acquired. This was completed to track changes that might occur at every step of the process 







Figure 4. 2 SEM of DMPS-PDMS modified membranes with images (a), (b) and (c), 
representing the silanisation stage of the membrane modification process ×500 magnification 
 
Based upon the images in Figure 4.2 (a and b) it can be seen that there are some tiny particle-
like features on the membrane surface, this could be monolith as a result of membrane transfer 
from the reactor onto the aluminium foil they were placed on, before being introduced to the 
oven. However, these are probably only loosely attached to the membrane, hence would not 
present any serious concern when considering the membrane for permeation analysis. 
The modified membrane was subsequently conditioned under nitrogen atmosphere, to improve 






Figure 4. 3 SEM of DMPS-PDMS modified membranes, following exposure to nitrogen with 
images (a), (b) and (c), representing different samples of membrane ×500 magnification 








Figure 4. 4 Comparative SEM images of PDMS, normal membrane (a) plasma treated (over 
cured) (b), plasma treated (optimised) (c), glycerol-coated (d), DMPS modified (e), and 
DMPS-modified (conditioned under nitrogen atmosphere) (f) -PDMS membranes, 






Following different modification processes established thus far in this study, a comparative 
SEM analysis becomes necessary at this stage to track changes with ease. Specifically, in 
relation to this chapter, there is not much difference between Figure 4.4 (e) and (f). However, 
Figure 4.4 (e) shows some dark patches on the membrane surface which was attributed to 
remaining moisture content that may be present on the observed sample. Following the 
membrane being conditioned under nitrogen (Figure 4.4 (e)), it can be visualised that these 
dark patches have disappeared, and the membrane appeared more even and homogeneous, 
indicating a rather stable surface layer formation. 
4.2.4. Attenuated Total Reflectance-Fourier Transform Infra-red spectroscopy 
ATR-FTIR analysis was undertaken on the modified membranes with results presented in 
Table 4.1. 










D - PDMS 
νs (CH3) 2962.4 2962.0 
 
2962.3 
δas (CH3) 1411 1411.9 
 
1412.1 
δs (CH3) 1257.1 1257.8 
 
1257.2 
Si-O 478 475 
 
477 
O-SiCH3 784.6 783.7 
 
783.1 
C-SiCH3 669.8 669.8 
 
699.3 




ATR-FTIR was used to analyse un-modified membrane, modified membrane as well as plasma 





formation. A comparison was necessary to effectively assess any change that might occur as a 
result of the modification process.  
It is paramount to realise that this method detects bond formations and not chemical entities, 
and only a small fraction of the surface is analysed compared with the effective area utilised 
for the overall permeation analysis process.  
A notable finding achieved was a decrease in peak intensity attributed to the Si-O backbone 
bond when comparing spectra representing plasma treatment and chemically modified 
membranes, this increase in intensity observed in the chemically modified membrane points to 
a significant resolve that can be attributed to the formation of alkoxysilanes. 
However, there were limitations when trying to ascertain aromatic overtones which 
theoretically were supposed to emerge after chemically modifying the membrane. This 
challenge could be as a result of the detector positioned deep inside the membrane matrix, 
possibly surpassing surface groups. Hence, other surface techniques were employed at a later 
stage of the analysis to address this concern.  
Methyl groups were confirmed by symmetrical stretching vibrations at 2962.4, 2963.0 and 
2962.3 cm-1 for un-modified, plasma treated and modified membranes respectively. Despite 
plasma treatment, the presence of methyl groups on the plasma treated membrane was seen and 
were attributed to underlying methyl groups, because only the membrane surface was targeted 
with the plasma treatment. Therefore, ATR-FTIR analysis was confirmed as having the ability 
to detect bond signals embedded within the polymer matrix.  
Asymmetric deformations of methyl groups from the membranes were also observed at 
approximately 1411 cm-1, and symmetric deformation of methyl groups for modified, un-
modified and plasma treated membranes were at 1257.2,1257.1 and 1257.8 cm-1 respectively. 





bonds, it is of paramount importance to note an increase in intensity of this peak from modified 
membrane, which further suggests the occurrence of the alkoxysilanisation. The presence of 
O-SiCH3 was confirmed by peaks at 783.1, 784.4 and 783.7 cm
-1, the presence of C-SiCH3 
groups were confirmed with peaks at 699.3, 669.8 and 669.8 cm-1. Peaks from un-modified 
membrane were in close agreement with those from literature, (Bodas & Khan-Malek, 2006), 
(Kim & Jeong, 2011), especially for the modified membrane which was anticipated. 
These characteristic changes in intensity and new peak formations observed using the ATR-
FTIR technique (prior to and following membrane modification) confirmed the suitability of 
the technique to detect such changes had occurred. 
4.2.5. Permeation analysis (Waters & Sabo, 2020) 
Compounds ranging from different therapeutic classes such as anaesthetics, non-steroidal anti-
inflammatories (NSAID), keratolytic agents, xanthine, and some anti-microbial or preservative 
compounds used in producing cosmetics were employed as model compounds to analyse 
permeation profiles through DMPS-PDMS modified membrane, as presented in Table 4.2. 
Relevant physicochemical properties of these compounds are also presented to help consider a 
more logical, robust and informed conclusion as to what factor(s) really contribute or influence 
any change that may occur in the permeation pattern of the newly developed membrane. 










Table 4. 2 A summary of log P, molecular weight, hydrogen bond donor (HBD), hydrogen 
bond acceptor (HBA) count, polar surface area (PSA), and log D of compounds i.e., 
antipyrine (ATP), benzocaine (BEN), caffeine (CAF), diclofenac (DF), ethyl paraben (EP), 
ibuprofen (IBU), ketoprofen (KTF), lidocaine (LID), pentoxifylline (PXF), procaine 
hydrochloride (PCN), salicylic acid (SA), and tetracaine (TTC). 
 










1. DF 4.98 296.14 123.8 617.5 2 3 49 1.37 
2. KTF 3.29 254.28 85.7 169.8 1 3 54 0.06 
3. EP 2.76 166.17 323.7 573.7 1 3 47 2.48 
4. BEN 2.2 165.19 2294.8 3787.9 1 3 52 1.83 
5. IBU 3.5 206.28 1176.2 2006.3 1 2 37 0.45 
6. PCN 2.14 272.77 33.4 56.8 2 4 56 0.29 
7. LID 1.81 234.34 3351.3 5048.7 1 2 36 1.26 
8. TTC 3.54 264.36 1551.0 2832.8 1 4 42 2.26 
9. ATP 1.18 188.23 313.3 450.1 0 2 24 0.74 
10. SA 1.96 138.12 862.4 1196.4 2 3 58 -0.77 
11. CAF -0.24 194.19 72.0 87.5 0 3 58 - 
12. PXF 0.08 278.31 79.5 74.6 0 4 76 0.54 
 
*  Mol.wght – Molecular weight 
*  CMP (µg/cm2) N-PDMS – Cumulative mass permeated (µg/cm2) of normal PDMS membrane 
*  CMP (µg/cm2) D-PDMS - Cumulative mass permeated (µg/cm2) of DMPS modified PDMS membrane 
*  Mol.wght – Molecular weight 
*  log D – Distribution coefficient  
*  PSA – Polar surface area 
*  HBD - Hydrogen bond donor 





• log P source DrugBank (Uniformly considered for linearity of data) 
NB. The value of log P can be different depending on the source and often can be different according to methods 
used in obtaining the results 
 
Following permeation analysis through PDMS membrane and modified DMPS-PDMS 
membrane (Figure 4.5), differences were observed between the membranes. 
 
Figure 4. 5 Comparative steady state flux of salicylic acid, ethyl paraben and diclofenac 
through PDMS, Plasma Treated, and DMPS modified membranes 
 
For ease of comparison Table 4.2 was compiled to instead consider the percentage increase 
observed following permeation studies, specifically between PDMS membrane and DMPS-






Table 4. 3 Percentage increase (% incr.) of compounds i.e., antipyrine (ATP), benzocaine 
(BEN), caffeine (CAF), diclofenac (DF), ethyl paraben (EP), ibuprofen (IBU), ketoprofen 
(KTF), lidocaine (LID), pentoxifylline (PXF), procaine hydrochloride (PCN), salicylic acid 
(SA), and tetracaine (TTC), that permeated through normal and DMPS PDMS membranes 
 
 Compounds % Incr. 
1. DF 398 ± 7.8 
2. KTF 98 ± 6.1 
3. EP 77 ± 3.9 
4. BEN 65 ± 3.1 
5. IBU 70 ± 3.2 
6. PCN 70 ± 2.3 
7. LID 50 ± 2.5 
8. TTC 82 ± 5.4 
9. ATP 43 ± 2.8 
10. SA 38 ± 2.1 
11. CAF 21 ± 3.0 
12. PXF -6 ± 0.1 
 
*  % Incr – Percentage Increase 
 
• log P source DrugBank (Uniformly considered for linearity of data) 
NB. The value of log P can be different depending on the source and often can be different according to methods 
used in obtaining the results 
 
Percentage increase represents the percentage difference in cumulative mass (µg/cm2) 
permeated over a 6-hour period (Table 4.3) between modified and un-modified membrane, and 





Mean percentage increase = (
cummulative massmodified−cummulative massun−modified
cummulative massun−modified
) × 100  
                    Equation 4.1 
 
The increases observed in Table 4.3 indicate that even though the modification was only on the 
membrane surface, the overall effect on membrane permeation was quite significant. The 
manner in which Table 4.3 was presented is to enable easy correlation between percentage 
increases with respective physical parameters of the compounds.  
Lipophilicity of compounds often expressed as log P, is a distribution co-efficient and 
represents relative ratios of a compound in an organic and aqueous solvent at the standard 
physiological pH of 7.4 (Arnott & Planey, 2012). The parameter is crucial in determining 
ADMET (absorption, distribution, metabolism, excretion and toxicity) and more specifically, 
it is also reported to influence extent of permeation in epidermal tissues and synthetic lipophilic 
membranes (Baba, Takahara, & Mamitsuka, 2015), (R. O. Potts & R. H. J. P. r. Guy, 1992; 
Zhang et al., 2012). Lipophilicity has various pharmacokinetic implications such as the way 
and manner compounds are distributed via biological tissues and accordingly is paramount in 
predicting how these distributions can be predicted (Hou, Wang, Zhang, Wang, & Xu, 2006; 
Testa, Crivori, Reist, & Carrupt, 2000). Hence, it was amongst the physical parameters 
considered for analysis of this result.  
It was found that compounds with comparatively high log P values tended to have a greater 
permeation percentage increase when compared with their corresponding permeation profile 
for PDMS membrane. In other words, a linearity was achieved between compounds having 
high log P values and percentage increase in permeation profiles. Therefore, it is not surprising 
for diclofenac - having the highest log P value of 4.51 (Reymond, Awale, Probst, & Capecchi, 
2019), (amongst the compounds used), displayed the highest percentage increase. In agreement 





lowest log P values also had the lowest percentage increases. Overall a linear correlation was 
obtained when comparing literature log P values with percentage increase (R2 = 0.9). 
Extent of the effect achieved in terms of permeation profile change amongst standard PDMS 
membrane and its modified forms can be exemplified in a graphical representation as seen in 
Figure 4.6. 
 
Figure 4. 6 Comparative permeation profiles of model compounds, permeated through 
PDMS, Plasma Treated, and DMPS modified membranes 
 
Another quite interesting phenomenon was how the compounds appeared to behave partially 
according to their pharmaceutical classes (in terms of percentage increase), even when these 
compounds have a relatively substantial variety of log P values. It could be observed that the 
anaesthetics i.e. benzocaine (log P 2.2, 65 % increase), tetracaine (log P 3.54, 82 % increase) 
and procaine (log P 2.14, 70 % increase), behaved in a similar manner. In other words, these 





In summary, it has been established that there is a clear relationship between higher log P values 
and an increase in comparative permeation for the model compounds analysed across the 
modified membrane, as summarised in Figure 4.7. 
 
Figure 4. 7 Graphical representation of serially arranged log P values, in descending order, 
versus percentage increases in permeation profile (obtained between PDMS and modified 
PDMS) 
 
It was additionally observed that an inverse relationship existed between log P value and the 
amount of cumulative mass permeated in (µg/cm2) (CMP), amongst model compounds with 
similar chemical functionalities. For instance, this was seen for compounds with basic amino 





2294 µg/cm2) and tetracaine (log P 3.54, CMP 1551 µg/cm2) have shown a decrease in 
cumulative mass permeated over 6 hours, as their log P values tend to increase. 
 
Figure 4. 8 Structural representation of lidocaine, benzocaine and tetracaine highlighting their 
similar functional groups 
 
This phenomenon, however, was not surprising as Moss et al have reported a similar behaviour 
exhibited when using human skin (Moss, Gullick, & Wilkinson, 2016). The surface of human 
skin comprises of a disproportionate heterogeneous mixture which is largely lipophilic. 
Therefore, lipophilic compounds are considered more favoured in terms of transdermal 
permeation. However, there is a flipside when it comes to compounds having high log P values 
(log P > 2), as they tend to get retained in this route, discouraged against permeating-out in a 
timely manner. In other words, there is poor clearance of these compounds out of the route into 
the underlying layer. It is therefore understood that compounds with log P values between 1< 
log P > 3, are the most suitable for transdermal drug delivery (Moss et al., 2016). This could 
be the explanation for the decreased cumulative permeation profile observed in some of the 
model compounds as their log P values tend to increase, when comparing data for PDMS 
membrane against the modified form of the membrane. This further shows a similarity in 
behaviour between the modified membrane and human skin. Similarly, caffeine and 
pentoxifylline (both xanthines) were also observed to a show similar trend.  
A study carried out by Bhuiyan et al, 2017, reported that the introduction of hydrophilic groups 





compounds through the membrane, this phenomenon, the authors added, was as a result of 
‘reduced partitioning of the permeant into the membrane’ (Bhuiyan, Waters,  2017). It was 
based on this understanding that some researchers have hypothesised a correlation between 
polar surface area (PSA) and permeation profile of PDMS membrane. The hypothesis was such 
that, ‘partitioning of compounds with high polar surface area may be less affected by the 
introduction of polar functionalities on PDMS membrane, conversely, compounds with low 
polar surface area, will display low partitioning into the outermost hydrophilic polymer layers’. 
This theory wasn’t entirely the case in this analysis, as it was observed that although the 
partitioning effect can be very crucial in permeation of pharmaceutical compounds via PDMS, 
it was less influenced by PSA of the compounds, but rather, it was more likely influenced by 
the newly formed additional surface layer, as little or no correlation was drawn between PSA 
and permeation profile. 
4.2.7.1 Comparison with Human Skin Data 
The cumulative amount of drug permeated through PDMS membrane and that of the modified 
membrane, were converted to permeation co-efficient values (Kp), and these values were 
compared to values representing human skin, obtainable from literature. Kp were scrutinised 
on the basis of tissue type, and physicochemical parameters used in the experiments, for 










Table 4. 4 Cumulative mass (μg/cm2), and permeation coefficient (Kp) x 10
-4 cm/min) values 
of lidocaine (LID), ketoprofen (KTF), salicylic acid (SA), ethyl paraben (EP), ibuprofen 
(IBU), diclofenac (DF), procaine hydrochloride (PCN), antipyrine (ATP), pentoxifylline 
(PXF), tetracaine (TTC), caffeine (CAF) and benzocaine (BEN) permeated through N-PDMS 










(Kp) × 10−4 (cm/min) 
N-PDMS D-PDMS N-PDMS D-PDMS Literature 
1 LID 
 










































-0.24 72 87.5 0.1 0.1 0.1 (Uchida et 
al., 2015) 




*  Mol.wght – Molecular weight 
*  CMP (µg/cm2) N-PDMS – Cumulative mass permeated (µg/cm2) of normal PDMS membrane 
*  CMP (µg/cm2) D-PDMS - Cumulative mass permeated (µg/cm2) of DMPS modified PDMS membrane 
*  Kp – Permeation coefficient (Flux) in micrograms per centimetre squared (μg/cm2). 
 
• log P source DrugBank (Uniformly considered for linearity of data) 
NB. The value of log P can be different depending on the source and often can be different according to methods 






To effectively compare data with that of human skin, an additional physical parameter for total 
amount of drug permeated through the membrane over 6 hours i.e. Kp, was introduced and is 
represented in micrograms per centimetre squared (μg/cm2).  
From Table 4.4, a considerable difference was obtained when trying to compare values from 
modified membrane alongside standard literature, using the descriptive factor (Kp), considering 
the literature values originated from skin data. It is obvious that a reduced value from modified 
membrane would constitute a better skin mimic system. However, a regular increased pattern 
corresponding to certain drug properties, or a robust predicted behaviour of the modified 
membrane if achieved would constitute a good skin replacement, irrespective of the increase 
in permeation.  
Overall, a plausible change in surface morphology of DMPS-PDMS was achieved in terms of 
its permeation profile. Difficulty in measuring permeation of some hydrophilic compounds 
(Miki et al., 2015a) such as caffeine, pentoxifylline and antipyrine when using PDMS has also 
been overcome following the silanisation process, however, it is apparent that a lipophilic layer 
has been achieved rather than a heterogeneous layer, resulting in over-estimation, particularly 
for lipophilic compounds.  
4.2.6. Brunauer-Emmett-Teller Technique  
Having established a modified layer that results in a change in permeation profile (Table 4.4), 
it was necessary to ascertain if this change is as a result of surface interaction only, or the 
integrity of the membrane has been affected during the modification process. Brunauer-
Emmett-Teller Technique (BET) was used to determine porosity of the polymer material. More 
specifically, it was used to comparatively determine if there was any change regarding porosity 





Un-modified membrane was seen to have zero porosity (0 m2/g) indicating the membranes 
were non-porous, and in conformity with its true nature. Similar results were obtained by 
(Nakade, Ichihashi, Ogawa, & technology, 2005), when analysing PDMS samples. The non-
porous nature of the membrane makes it a good candidate for this study and was the reason it 
is considered a possible analogue for skin and hence, substances could only permeate through 
the membrane. Therefore, it is vital to ensure that this feature is maintained throughout the 
process of modification rather than creating a membrane that allows compounds to freely pass 
through a porous structure. 
Interestingly, the same value (0 m2/g) was obtained when analysing the modified membrane, 
thus confirming that the increase in permeation is attributed to selective permeation and not 
porosity. It can, therefore, be confirmed that the chemical modification process has not 
compromised the membrane integrity and concerns arising from a mere physical modification 
were addressed with the help of this technique. Data acquired for this analysis are displayed in 













4.2.7. Optical Microscopy 
Optical microscopy was utilised to characterise the membranes studied through surface 
observation, as shown in Figure 4.9.  
 
Figure 4. 9 Optical microscopy images for (A) PDMS, (B) plasma treated PDMS, and (C) D-
PDMS at x 250 magnification 
 
The surface appearance between different modified membranes could be seen following 
magnification. In Figure 4.4 (a) and (b) little difference could be observed, this shows that there 
was little or no physical change following the initial plasma treatment and the integrity of the 
membrane was not compromised.  
This finding is confirmed when considering the results achieved from permeation analysis 
(Table 4.4) indicating cumulative mass of drugs permeated over 6 hours shows no considerable 
difference between un-modified and plasma treated membranes. 
In contrast, a reasonable physical difference could be seen from the modified membrane, in 
comparison with the plasma treated and un-modified membranes, Figure 4.4 (a), (b), and (c) 
respectively. An increase in surface roughness and the presence of discontinuous patches can 
be seen in Figure 4.4 (c), which are attributed to the chemical treatment undergone by the 





might result in an increase in porosity could be seen from the image presented. These un-even 
patches which must be attributed to the chemical modification process, may have been part of 
the explanation for the detection difficulties experienced in ATR-FTIR analysis (Figure 4.10).   
                                               
    
Figure 4. 10 Optical microscopy image of  D-PDMS at x 250 magnification, illustrating the 


















4.3. Sequential Silanisation using Tertbutyldimethylsiloxane 
Utilisation of tertbutyldimethylsiloxane (TBDMS) was inspired by the work of Potts and Guy 
(R. O. Potts & R. H. Guy, 1992). In their pioneering work, they describe an increase in 
molecular weight, or molecular volume, to negatively influence the permeation coefficient. In 
other words, an increase in carbon chain length can be concomitant in reducing permeation 
through sample membrane.  
However, following the silanisation process (method not presented), the resultant modified 
membrane, i.e. TBDMS modified – PDMS (T-PDMS), was found to have an increased 
percutaneous absorption profile when compared with plasma treated PDMS membrane. This 
result was somewhat unsurprising as an additional layer on the surface of the membrane was 
more likely to be formed in contrast to a heterogeneous layer, which is similar to skin. 
Interestingly, Cronin et al reported findings relating polymeric systems with ‘alternating 
hydrophobic and hydrophilic layers’ to provide a more robust system in terms of skin mimics, 
rather than two distinct layers (Cronin, Dearden, Gupta, & Moss, 1998). 
Additionally, Addicks et al presented a finding that entails the permeation of alkyl 4-








Figure 4. 11 Permeability coefficient of alkyl 4-aminobenzoate permeated via silicon 
membrane. Adopted from Addicks et al, 1987. 
 
Figure 4.11 displays how an increse in carbon chain lengths in silicon membranes can lead to 
an increase in diffusion coefficient. However, it was proposed in the work that ‘as chain length 
increases, a plateau is reached, where rate of diffusion is no longer predominantely controlled 
by the membrane material itself, instead by an aqueous diffusion layer formed’. Following this 
work, it was considered that an additional layer made up of TBDMS was formed on the surface 
of the plasma treated membrane, hence instead of achieving an additional carbon chain 
membrane, a covalently attached layer was formed on the PDMS surface, and therefore, the 
rate of diffusion was primarily controlled by the additional layer formed.  
4.4. Sequential Silanisation using Perfluorophenylsilanol 
In this study the electronegativity of fluorine groups present in the pre-cursor reagent 
(perfluorophenylsilanol) was aimed to bring about a substantial change in the surface chemistry 
of PDMS. It was envisaged that this change could possibly be significant enough to alter 





4.4.1. Comparative permeation profile between Perfluorophenylsilanol treated PDMS 
and PDMS membrane 
 
Following the modification process, permeation analysis was carried out on 
perfluorophenylsilanol treated PDMS membrane (P-PDMS) and compared with PDMS 
membrane, as displayed in Figure 4.12. 
 
Figure 4. 12 Comparative steady state flux of lidocaine and ibuprofen compounds through 






From Figure 4.12 it can be seen that the newly formed membrane differs from the standard 
PDMS membrane, however, changes observed were somewhere in between permeation 
profiles of D-PDMS and standard PDMS. Therefore, this result was not distinct enough to 





















A series of modification processes have been depicted in this study, as summarised in Figure 
4.13. 
 
  Figure 4. 13 Summary of silanisation processes employed in this study  
 DMPS-PDMS modified membrane has shown the most desirable change in permeation profile 
of model compounds analysed. More importantly, a similarity was established between 
behaviours of these model compounds permeated via the modified membrane, with permeation 
behaviours of compounds exhibited by skin. With the help of some spectroscopic techniques, 
it was also established that indeed an additional layer had been deposited on the surface of 





positively indicates the initial stability of the membrane, along with a stable activity throughout 
the process.  
A good correlation (R = 0.9) has also been established between a physicochemical parameter 
(log P) with a comparative percentage increase between modified and unmodified PDMS 
membranes. This is to say a robust membrane capable of establishing a defined pattern has 
been achieved, and by extension, it could form the basis for a predictive model. Furthermore, 
the modified membrane was able to provide a novel achievement, by allowing the analysis of 
hydrophilic compounds such as the xanthines used in this study, which before now has been 
reported as a constraint for silicon membranes in permeation analysis, especially PDMS. The 
hydrophobic nature of the membrane was the main reason behind this constraint and changes 
observed in permeation profiles through DMPS-PDMS modified membrane confirm the 
proposed establishment of an additional layer. 
Instead of an emulsified layer impregnated within the membrane matrix, it was believed that 
an additional layer was formed on the membrane surface, which then proceeded to serve as the 
rate determining factor for permeation flux. In other words, it provided a lipophilic partition 
that increased the affinity of lipophilic compounds towards the surface of the membrane, 
thereby increasing their permeation. This understanding has therefore paved an informed idea 
on how to create membranes with heterogenous surfaces which will better mimic skin in terms 
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Chapter 5  



















Having presented a modified PDMS membrane in Chapters 3 and 4 that predominantly 
comprises of a hydrophilic and lipophilic surface layer respectively, it is proposed, that a 
modified PDMS polymer membrane that has a heterogeneous layer comprising of both 
hydrophilic and lipophilic regions, reigns supreme in mimicking human skin for prediction of 
percutaneous absorption. In order to effectively achieve this proposed idea, the concept of 
smart polymerisation is considered in this chapter.  
Smart polymers or ‘stimuli responsive polymers’, are polymers that can reversely respond to 
physicochemical effects. These effects can be changes in temperature or  pH (Majcen, Mohsen, 
Snowden, Mitchell, & Voncina, 2018), light intensity and the presence of biological molecules 
at a macroscopic level, often characterised by swelling, group rearrangements, collapse or sol-
to-gel transitions, depending on the physical state of the chains (Maria Rosa Aguilar, Elvira, 
Gallardo, Vázquez, & Román, 2007; María Rosa Aguilar & San Román, 2019). The idea of 
creating a smart polymer for percutaneous permeation analysis is coined from the hydrophobic 
nature of PDMS. Hydrophobic and lipophilic terms are often used interchangeably, probably 
because most hydrophobic substances are also lipophilic. However, it is important to note that 
certain materials, such as fluorocarbons and silicones, are an exception to this stereotype.  
Results presented in Chapter 4 indicate that PDMS membrane does not encourage the 
adsorption of lipophilic compounds, to the extent that rather deliberate attempts need to be 
made towards achieving a permeable surface. However, it is quite understandable that the 
hydrophobic nature of PDMS makes it difficult to introduce aqueous substances on its surface 
(Hu et al., 2002). These combined effects exhibited by the membrane need to be harmonised 






5.2. Smart PDMS membrane 
5.2.1. Background  
An alternative approach that involves grafting a smart co-polymer layer incorporated on 
modified Dimethyphenylsilanol-Poly(dimethylsiloxane) (D-PDMS) membrane was proposed. 
In this approach, an amphiphilic poly(dimethylsiloxane) and poly(ethyleneglycol) block co-
polymer PDMS-PEG BCP, was identified, partly due to the hydrophilic nature of PEG co-
polymer. This co-polymerisation graft approach has been previously reported in some related 
studies. For instance, PEG has been grafted with polyacrylonitrile (PAN) (Asatekin, Kang, 
Elimelech, & Mayes, 2007; Asatekin & Mayes, 2009; Kang, Asatekin, Mayes, & Elimelech, 
2007) and poly(vinylidenefluoride) (Kaner, Rubakh, & Asatekin, 2017), which enabled the 
resultant filtration membranes to have excellent fouling resistance. 
Other studies that specifically reported the use of a PDMS-based additive namely PDMS-PEG 
BCP, have also been reported, which in part, motivated the selection of this additive. Yao et al 
reported in their work that the addition of PDMS-PEG BCP improved surface hydrophilicity 
of PDMS membrane, reducing water contact angle to 21.5 – 90.8° from 112°, thereby 
increasing its hydrophilicity (Yao & Fang, 2012). Similarly, another study was carried out 
using the same additive, primarily to address stability and hydrophobic recovery often 
associated with the membrane. It was also reported in the study that PDMS-PEG BCP 
segregates when in contact with water, creating a surface re-arrangement with the PEG 
positioned on the membrane surface. In other words, PEG which is far more hydrophilic than 
PDMS, forces a displacement reaction within the PDMS-PEG BCP matrix when in contact 
with water (Gökaltun, Kang, Yarmush, Usta, & Asatekin, 2019). While these studies and other 
similar approaches have increased hydrophilicity, stability and smart re-orientation of PDMS-
PEG BCP, their broader use in biopharmaceutical areas such as drug delivery and controlled 





This approach has not been utilised to produce a membrane for the purpose of predicting 
percutaneous absorption prior to this study.  
5.2.2. D-PDMS - PDMS-PEG BCP method 
From earlier modification (Section 4.2.2), it was possible to establish a modified form of PDMS 
that had a lipophilic surface i.e. D-PDMS. This established form of the membrane was then 
cured and grafted with PDMS-PEG BCP. 
Commercially available PDMS-PEG BCP comprises of 60-70 % PEG and anchors on the 
PDMS base. The material is linked to D-PDMS with the help of a plasma treatment process, 
enabled by existing protocols with no added steps. Based on available literature, and earlier 
studies carried-out, it was proposed that this new form of modified PDMS will rather have a 
multi-layered structure which will selectively control permeation on the basis of the hydro-
lipophilicity parameter. In other words, this newly modified PDMS membrane will act as a 
smart polymer by selectively re-orienting upon contact with foreign substances, primarily on 
the basis of their polarity (Figures 5.1 and 5.2).  
 
 
Figure 5. 1 Schematic representation of proposed surface re-arrangement exhibited by 








Figure 5. 2 Schematic illustration of distinct layers present in the formation of smart-PDMS 
membrane proposed in this study. 
 
5.2.2.1 Schematic representation and process methodology  
PDMS silicon membrane, 0.3 mm thickness with approximately 0.6 cm
2 
size was utilised in 
this process. The membrane was plasma-treated then cured with 1 mL dimethylphenylsilanol. 
The process was a wet process, and the reaction was carried out in an ethanolic medium (~ 5 
mL). PDMS-PEG BCP curing agent was also added to the reactor (~ 1 mL). The entire reaction 
process lasted for 2 hours. 
Subsequently, the membrane formed was placed on an aluminium foil covered glass plate and 
introduced in an oven adjusted to 50 ℃ for 24 hours to completely cure and evaporate any 





The overall methodology is displayed in Figure 5.3.
 





5.2.3. Attenuated Total Reflectance-Fourier Transform Infra-red spectroscopy 
ATR-FTIR analysis was undertaken with results presented in Table 5.1 and Figure 5. 4. 
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Figure 5. 4 Independent ATR-FTIR spectra for PDMS-PEG BCP, smart-PDMS and PDMS 
membrane 
 
Upon modifying PDMS membrane with the newly introduced PDMS-PEG BCP reagent, and 
dimethylphenysilanol, a chemical change in their respective spectra was observed with the help 
of ATR-FTIR spectroscopy. In Figure 5.4 notable changes between the three different forms 
of the membranes included changes in Si-O-Si stretching vibrations, seen in the spectrum of 
the developed smart PDMS (S-PDMS). This change in bond stretching was attributed to the 
proposed newly formed alkoxysilane bond, similar to the findings of others (Pissetti, Araújo, 
Silva, & Poirier, 2015). Additionally, an absorption band at 478 cm−1 was attributed to the 
symmetric stretching of Si-O-Si resulting from the (Si-O) siloxane unit. This was observed in 
the PDMS spectrum but absent for PDMS-PEG BCP. The bond was seen to appear at 478 
cm−1in S-PDMS. This was probably as a result of a local gradient that may draw and integrate 
the bulk PDMS base to the introduced PDMS-PEG BCP additive, thereby creating some sort 
of interaction. This phenomenon solidifies a chemical reaction process had occured amongst 





Another change observed was in the peak at 2874.9 cm−1 attributed to the ethylene group (νs 
CH2) from PDMS-PEG BCP, similar to peak identification presented in (Galhenage et al., 
2017). This peak was not present in PDMS, obviously due to the absence of PEG co-polymer. 
However, following the modification process, a peak at 2883.6 cm−1 was observed, also 
indicating the occurrence of a chemical change. Another interesting aspect noteworthy is how 
the developed S-PDMS membrane spectrum indicated all expected bonds, in line with the 
proposed reaction scheme depicted in Figure 5.3. 
Other observed bonds included methyl groups which were confirmed by symmetrical 
stretching vibrations at 2982.4, 2990.1 and 2991 cm-1 for PDMS, PDMS-PEG BCP and S-
PDMS membranes respectively. Asymmetric deformations of methyl groups from the 
membranes were also observed at approximately 1412 cm-1 and symmetric deformation of 
methyl groups for PDMS, PDMS-PEG BCP and S-PDMS membranes were at 1272.7,1277.5 
and 1278.1 cm-1 respectively. The presence of O-SiCH3 was confirmed by peaks at 771.2, 778.2 
and 783.1 cm-1, the presence of C-SiCH3 groups were confirmed with peaks at 680.3, 677.7 
and 680.6 cm-1. Peaks from PDMS membrane were in close agreement with those from 
literature, (Bodas & Khan-Malek, 2006), (Kim & Jeong, 2011).  
5.2.4. Permeation analysis and measurement. 
A similar permeation analysis methodology as reported in Section 2.3.1.7 was adopted. 
However, high performance liquid chromatography (HPLC) was introduced to serve as a 
confirmatory technique, in addition to the previously reported UV-visible technique.  
Details of HPLC parameters are presented in Section 2.3.1.8. 
5.2.4.1. HPLC Method Development 
A series of caffeine (selected model drug) concentrations i.e. 2, 4, 8, 16 and 20 ppm, using de-





graph with an R2 value of 0.9998 was obtained. Serial dilutions for the calibration plot were 
slightly adjusted to 8, 16, 20, 24 and 32 ppm in the subsequent experiments, which was for 
convenience, but with the same stock solution of 1000 ppm. All subsequent R2 values were in 
concordance with the first measurement.  
All reported analysis using caffeine were carried out at an established wavelength of 271 nm, 
which was also in line with reported literature (Seyedabadi, Rostami, Jafari, & Fathi, 2020; 
Xhaferaj, Peculi, Kopali, Shkurti, & Hoxha) at a total running time of 30 minutes. A single 
peak was seen at approximately 3.02 minutes, with an injection volume of 10 µL, which was 
attributed to caffeine (Figures 5.5 and 5.6). 
 
Figure 5. 5 Chromatogram of caffeine at a concentration of 8 ppm, and a peak at 







Figure 5. 6 Caffeine calibration at 271 nm using HPLC 
Subsequently, after identifying the caffeine peak at a retention time of 3.02 minutes, sample 
solutions obtained from previously performed permeation analysis using modified smart 
PDMS membrane were analysed. Peaks with similar retention times (~ 3.0 minutes) were 
obtained from samples which was easily attributed to caffeine due to the consistency of the 
retention times (Figure 5.7). The resultant peak area obtained was integrated and drug 
concentration calculated.  





















Figure 5. 7 Chromatogram of caffeine solution at a concentration of 8 ppm, indicating a peak 
at approximately 3.0 minutes 
However, a few unknown additional peaks (1.91 and 2.70 minutes) appeared following analysis 
of the sample, as displayed in Figure 5.7. These peaks were most likely from a leaching effect 
often attributed to PDMS membrane. As such, a control analysis was employed which 
comprised of the modified and un-modified membranes under the same experimental 














In Figure 5.8 a caffeine peak at ~ 3 minutes was largely absent in the chromatograms. Figure 
5.8a (PDMS-PEG) indicated the same unidentified peak at a similar retention time of 1.91 
minutes. Figure 5.8b also showed the same peak of interest ascertained by a similar retention 
time of 1.92 minutes. These results imply a logical conclusion that the peak of interest 
appearing at a retention time of approximately 1.91 minutes was as a result of a leaching effect 
from the bulk PDMS membrane. It was also ascertained that this peak has no effect in the 
overall permeation analysis of the model drug compound. 
5.2.4.1 Permeation data 
For effective comparison of data presented in this study with data obtainable from literature, 
flux can be calculated from cumulative amount of drug permeated through any form of silicon 
membranes using the following equations, which is in line with Flynn’s work (G.L. Flynn, 
1974). 
    Flux = 
𝐶𝑣𝐾𝐷
𝐿
 = P.𝐶𝑣    Equation 5.1 
    𝐷𝐿−2 = 
1
6.𝑇𝑙𝑎𝑔
     Equation 5.2 
    KL = 6. 𝑇𝑙𝑎𝑔. P    Equation 5.3 
Where Cv is concentration of the compound, and Tlag is calculated from intercept of the slope 
on the x-axis of the graph (time axis), obtainable after steady state is achieved (according to 
Fick’s first law) from the permeation profile of each model compound.  
 
A summary of the physicochemical properties and cumulative mass permeated for a group of 









Table 5. 2 Physicochemical properties of ketoprofen (KTF), ethylparaben (EPB), ibuprofen 
(IBU), lidocaine (LID), tetracaine (TTC), and caffeine (CAF) model compounds used in 
present study, alongside their cumulative mass permeated (µg/cm2) through PDMS and 
modified smart-PDMS 
 










1 KTF 3.29 254.28 85.7 45.9 1 3 54 0.06 
2 EPB 2.76 166.17 323.7 58.2 1 3 47 2.48 
3 IBU 3.5 206.28 1176.2 221.3 1 2 37 0.45 
4 LID 1.81 234.34 3351.3 921.3 1 2 36 1.26 
5 TTC 3.54 264.36 1551.0 114.7 1 4 42 2.26 
6 CAF -0.24 194.19 72.0 76.2 0 3 58 - 
 
*  Mol.wght – Molecular weight 
*  log D – Distribution coefficient  
*  PSA – Polar surface area 
*  CMP (µg/cm2) N-PDMS – Cumulative mass permeated (µg/cm2) of normal PDMS membrane 
*  CMP (µg/cm2) D-PDMS - Cumulative mass permeated (µg/cm2) of DMPS modified PDMS membrane 
*  HBD – Hydrogen bond donor 
*  HBA – Hydrogen bond acceptor 
 
• log P source DrugBank (Uniformly considered for linearity of data) 
NB. The value of log P can be different depending on the source and often can be different according to methods 
used in obtaining the results 
 
Following ATR-FTIR characterisation of the newly developed smart-PDMS (S-PDMS), 
permeation analysis was employed using the newly modified membrane and results obtained 
were compared with that of PDMS, as presented in Table 5.2. Evidently, a remarkable 
difference was observed in the permeation profile of these model drugs. One of the major 
shortcomings of standard PDMS in permeation analysis is over estimation of percutaneous 





& de Sousa, 2016; Uchida et al., 2016), yet based on this analysis, it can be said that this 
shortcoming has been potentially resolved, as displayed in Table 5.3.  
Table 5. 3 Percentage decrease (% decrse.) of compounds i.e. ketoprofen (KTF), ethyl 
paraben (EP), ibuprofen (IBU), lidocaine (LID), tetracaine (TTC) and percentage increase (% 
incr.) of caffeine (CAF), that permeated through smart PDMS membranes 
 
 Compounds % Decrse 
1 KTF 49.4 % 
2 EPB 82.0 % 
3 IBU 81.1 % 
4 LID 72.5 % 
5 TTC 92.6 % 
 
 Compounds % Incrse 
6 CAF 4.2% 
 
*  % Decrse – Percentage decrease 
*  % Incrse – Percentage increase 
 
From Chapter 4, model compounds showed very high percentage increases regarding 
permeation obtained using D-PDMS compared to PDMS. However, upon the modification in 
this chapter, the same model compounds, and under the same experimental conditions were 
seen to exhibit a drastic reduction in permeation, except for caffeine. This is to say, the effect 
of the modification employed in this section of the study has shown an impressive effect in the 
overall permeation profile behaviour of the membrane. However, due to the complexity of drug 
compounds, alongside various intrinsic properties often associated with polymer membranes, 






Aside from ionisation of drug compounds, lipophilic chemical groups, and bulky oxygenated 
side chains, solubility is also known to influence permeation of drug compounds, regardless of 
the process being passive or active. Part of the limitation in analysing the dataset presented 
herein, in terms of selectivity of the membrane, is the closely related physicochemical 
properties of the compounds. For instance, with the exception of caffeine, all the model 
compounds used belong to the Class II division according to the biopharmaceutics 
classification system. This could be part of the reason why they all show a decrease in their 
permeation when permeating through the smart membrane. Caffeine on the other hand, is a 
hydrophilic drug, with a log P value of -0.24, and the fact that an additional layer of PEG 
introduced in the membrane surface is hydrophilic, could result in an increased affinity of the 
drug compound to the membrane, thereby increasing permeation, unlike the rest of the 
compounds that are all lipophilic. 
5.3. Conclusion 
Overall, the modification process employed has been confirmed using ATR-FTIR, alongside 
permeation analysis where model compounds used (both hydrophilic and lipophilic) were 
quantified using UV-visible spectrophotometry and HPLC.  
The membrane developed has shown an impressive reduction in permeation compared with 
PDMS; this was previously a lingering issue when considering PDMS as a substitute for human 
skin in percutaneous absorption. Enhanced activity of the membrane can be attributed to a 
suitable balance amongst all the moieties present in the modification process from the co-
polymer used. This is to say, the PEG chain length can result in staggered delivery of 
compounds (Akimoto, Aoyagi, Minoshima, & Nagase, 1997) and, as a result, selectively 
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Chapter 6:  


















The primary aim of this research work was to produce an alternate inorganic synthetic polymer 
membrane capable of mimicking the surface activity of skin in terms of permeation analysis 
(primarily the measurement of drug percutaneous absorption), which is necessary before any 
transdermal drug is released on to the market. 
Poly(dimethylsiloxane) PDMS membrane was considered and initially the membrane was 
plasma treated using a non-thermal plasma technique, which resulted in activating the polymer 
surface, thereby making it susceptible for further modifications. Reported stability, selectivity 
and integrity of the membrane were vital in the intended purpose of this work, hence, a cautious 
approach mainly informed by literature to use a mild and non-invasive chemical method to 
modify the membrane was adopted. Skin structural activity was also carefully studied and 
critically analysed to guide direction of the modification. Keeping in mind some imperative 
constraints often posed by scientists regarding the use of synthetic membranes for in vitro 
analysis, such as the absence of viable cells to mimic activity of the living system with 
certainty, the approach was instead based on comparisons with permeation data obtainable 
from literature using skin. It was understood that permeation activity of the skin can be 
achieved without necessarily replicating its cellular structures or viable cells, as selective 
permeability of the skin is largely attributed to the topmost stratum corneum layer, which in 
itself is predominantly not made up of viable cells (Godin & Touitou, 2007; Guy, 2013; 
Herkenne, Naik, Kalia, Hadgraft, & Guy, 2007; K. W. Ng & Lau, 2015). 
Moreover, it was understood that poly(dimethylsiloxane) generally results in overestimation of 
percutaneous absorption (Simon et al., 2016; Uchida et al., 2016), a phenomenon that seems to 
persist even after reported attempts to modify the membrane for percutaneous absorption 





research work was to try and achieve a noticeable decrease in drug permeation through the 
membrane. After plasma treating the membrane, a slight reduction was achieved when results 
of the plasma treated membrane were compared with that of PDMS membrane using a set of 
model compounds that covered a wide range of therapeutic classes. This finding indicates a 
change in surface behaviour of the membrane. The change wasn’t sufficient enough to form a 
strong basis for adaptation hence, glycerol was further grafted on the plasma treated membrane 
via a simple condensation process. Although following this process a surface change of the 
membrane was confirmed using spectroscopic techniques such as scanning electron 
microscopy (SEM), water contact angle analysis (WCA), attenuated total reflectance 
spectroscopy- Fourier transform infrared spectroscopy (ATR-FTIR) and permeation analysis, 
changes in permeation profiles were not adequately similar to that of skin. 
Following on from that result, some chemical entities were also considered, this time focusing 
mainly on compounds that can incorporate lipophilic properties on the membrane. Compounds 
such as dimethylphenylsilanol, tertbutyldimethylsiloxane and perfluorophenylsilanol were 
selected for such purposes, mainly due to their reported lipophilic properties and chemical 
compatibility with plasma treated PDMS membrane. All the compounds utilised showed some 
changes in permeation profiles of the modified membrane accordingly, however, membrane 
that was treated with dimethylphenylsilanol, showed the most desirable change in terms of this 
research aim. This version of the membrane depicted a heightened affinity to lipophilic 
compounds (R2 = 0.9, for 13 compounds) when utilised for permeation studies, indicating a 
rather successful addition of the lipophilic layer on its surface. Moreover, stability and 
selectivity of the membrane was maintained throughout the duration of permeation analysis (6 






Based on these studies, it was apparent that poly(dimethylsiloxane) can be chemically modified 
to achieve an overwhelming change in permeation profile, more importantly, exhibiting these 
changes in a controlled and logical manner  (Waters & Sabo, 2020), and can be used to achieve 
data of highly hydrophilic drugs such caffeine, which in the past has also been an issue. Despite 
these recorded achievements, reduction of permeation through the membrane remained a 
challenge.  
As a result, the concept of a smart PDMS modified membrane was introduced. This concept 
was not to only selectively allow xenobiotics to permeate the membrane, it was also intended 
to reduce the permeation ability of compounds through the membrane. Permeation results for 
six model drugs using this newly developed smart-membrane indicated that five out of the six 
drugs displayed a remarkable reduction in their permeation profile, compared to PDMS alone. 
Analytical techniques, namely attenuated total reflectance spectroscopy- Fourier transform 
infrared spectroscopy (ATR-FTIR) and high-performance liquid chromatography (HPLC), 
were used to characterise the newly developed membrane. These findings provide the 
possibility for scientists to utilise this modified membrane to accurately and precisely predict 
permeation without the need to use animal or human skin, thus achieving the overall aim of 
this work. 
6.2. Future work 
Although this study can be deemed successful in regard to creating a polymer-based skin 
mimic, there are several potential avenues of interest for future work, including:  
 An increase in the number of model drugs used in analysing the newly 
developed smart PDMS membrane should be pursued, as this will not only allow 
a better understanding of how the membrane works but will also provide 





of interest to expand the study should span a wide range of log P values and also 
cut across different therapeutic classes to enable a more robust dataset. 
 The inclusion of alternative analytical techniques that could be used for surface 
analysis, such as X-ray photoelectron spectroscopy (XPS), and atomic force 
microscopy (AFM). These should be employed to further understand the surface 
chemistry of the modified membrane, as this will help in proposing a theory of 
how it functions. 
 In the long term, mathematical model equations should be generated using data 
acquired from the newly developed smart membrane as this will serve as a 
useful tool for primary screening of drugs intended for transdermal delivery.  
 Creation of alternative modified membranes. Promising membranes such as 
hydro- and microgels capable of exhibiting smart re-orientation have been 
widely explored. However, there have been limited considerations in modifying 
them for purposes of permeation analysis. Hence, these promising class of 
membranes should also be investigated, particularly to modify and tailor-fit 
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